PROTOCOL APP FULL DEMO

Content Loading,
Please Wait

emSop, LLC

Protocol App - Full Demo

ALS PROTOCOLS
INDEX













emSop, LLC

1000 - INTRODUCTION and OVERVIEW


    The Hennepin County Emergency Medical Services (EMS) system refers to a dedicated group of professionals working together to provide emergency medical services to patients and communities within Hennepin County. The EMS system is a dynamic mix of private and public providers including:

    • Ambulance Services
    • First Responders (Public Safety and Fire Services)
    • Dispatchers
    • Medical Control Hospital Physicians
    • Acute and Tertiary Care Emergency Facilities
    • County Public Health Staff

    The Hennepin County Board of Commissioners makes general policy decisions affecting the EMS system in response to recommendations from the Emergency Medical Services Advisory Council. The Hennepin County EMS Planning and Regulatory Unit (EMS Unit) is a division of the Human Services and Public Health Department and provides planning support and regulatory oversight for county's EMS system and assures coordinated emergency response to 911 calls.

    The Emergency Medical Services Council was established in 1976 to recommend to the Hennepin County Board of Commissioners and other appropriate authorities activities and processes necessary for the coordination and improvement of prehospital emergency services within Hennepin County. Communities of the council include:

    • Executive Committee
    • Operations Committee
    • Quality Committee
    • Medical Standareds Committee
    • Ambulance Medical Directors Subcommittee
    • Ambulance Service Personnel Subcommittee

    Five Advanced Life Support (ALS) ambulance services provide emergency medical care to Hennepin County residents. The Minnesota Emergency Services Regulatory Board (EMSRB) designates Primary Service Areas (PSAs) for ambulance service operation within the state of Minnesota. The five services which are authorized by the EMSRB to operate within Hennepin County are:

    • Allina Health EMS
    • Edina Fire Department
    • Hennepin EMS
    • North Memorial Ambulance Service
    • Ridgeview Ambulance Service

    ALS protocols and guidelines for Hennepin County's EMS system are reviewed and re-issued on an on-going basis. New protocol proposals and/or protocol revision proposals are reviewed by the Ambulance Service Personnel Subcommittee, the Ambulance Medical Directors Subcommittee and the Medical Standards Committee. The Emergency Medical Services Advisory Council is the final reviewing authority for protocol changes.

    Individuals interested in deveolping new ALS protocols and/or guidelines or interested in revising current ALS protocols and/or guidelines may request a Protocol Revision Form from the public health EMS Unit at chd.ems@hennepin.us, by calling 612-348-6001, or by visiting our website at www.hennepin.us/ems (NOTICE).

    AUTHORITY

    Each of the ambulance services operating a Primary Service Area (PSA) within Hennepin County has an ambulance service medical director. Per MN Statute 144E.265, Subd. 2, "Responsibilities of the medical director shall include, but are not limited to:

    1. Approving standards for education and orientation of personnel that impact patient care;
    2. Approving standards for purchasing equipment and supplies that impact patient care;
    3. Establishing standing orders for prehospital care;
    4. Approving written triage, treatment and transportation guidelines for adult adn pediatric patients;
    5. Participating in the development and operation of continuous quality improvement programs including, but not limited to:
      • Case Review
      • Resolution of Patient Complaints
    6. Establishing procedures for the administration of drugs;
    7. Maintaining the quality of care according to the standards and procedures established under clauses (1) to (6)."

    The policies and protocols in this document represent the collective medical expertise and authority of the medical directors for the five ALS ambulance services operating PSAs within Hennepin County. If any conflict exists between a service specific policy or protocol and a system policy, paramedics shall follow their serivce policy.

emSop, LLC

2001 - GUIDELINES


    1. These medical protocols are intended for use while working under the license of an Ambulance Medical Director for an ambulance service with a Primary Service Area (PSA) in Hennepin County.
    2. Remember: courtesy to the patient, the patient's family and other emergency care personnel is of utmost importance.
    3. A Patient Care Report (PCR) form must be completed on all patients and a copy left with the patient at the hospital. See www.hennepin.us/ems(NOTICE) for the Required Documentation Policy. Specific prehospital care information must also be recorded on all patient contacts as part of the MNStar requirements and Hennepin County system Data Collection Program.
    4. All equipment appropriate to the nature of the call for assistance, treatment and transport should be taken to the site of the patient at the time of the initial patient contact.
    5. In all circumstances, physicians have latitude in the care they give and may deviate from these Medical Protocols if it is felt such deviation is in the best interest of the patient. Nothing in these protocols shall be interpreted as to limit the range of treatment modalities available to meical control physicians to utilize, other than the modalities and the medications used must be consistent with the paramedic's training.
    6. The specific conditions listed for treatment in this document, although frequently stated as medical diagnoses, are operational diagnoses to guide the paramedic in initiating appropriate treatment. This document is to be used as consultive material in striving for optimal patient care. It is recognized that specific procedures and/or treatments may be modified depending on the circumstances of a particular case. Also, a medical control physician when consulted will either concur or further evaluate the paramedic's clinical findings and suggest an alternate diagnosis and treatment.

emSop, LLC

2010 - CRITICAL INCIDENT STRESS DEBRIEFING (CISD)


    1. Paramedics and other EMS personnel are encouraged to fammiliarize themselves with the causes and contributing factors of critical incident and cumulative stress, and learn to recognize the normal stress reactions that can develop from providing emergency medical services.
    2. A "Metro CISM Team" is available to paramedics and other EMS personnel. The program consists of mental health professionals, chaplains and trained peer support personnel who develop stress reduction activities, provide training, conduct debriefings and assist EMS personnel in locating available resources. The team will provide voluntary and confidential assistance to those wanting to discuss conflicts or feelings concerning their work or how their work affects their personal lives.
    3. Call 612-207-1130 to contact a Metro CISM Team.
    4. See www.metrocism.org(NOTICE) for further information.

emSop, LLC

2020 - DEACTIVATING IMPLANTABLE CARDIAC DEFIBRILLATOR


emSop, LLC

2030 - LIMITING RESUSCITATION MEASURES AND DNR


    1. Cardiopulmonary Resuscitation (CPR) will be promptly instituted for all patients found in cardiac arrest unless reliable criteria for the determination of death are present, or if a valid DNR or No CPR order exists.
    2. Reliable criteria for the determination of death include:
      • Lividity
      • Rigor
      • Obviously fatal trauma
      • Absence of vital signs in a trauma victom upon arrival of EMS personnel despite a patent airway

    3. Do Not Resuscitate (DNR, No CPR) orders are issued by a patient's physician to prevent rescuers from initiating resuscitative measures in the event of a cardiopulmonary arrest. Patients with DNR orders may receive vigorous medical support, including all interventions specified in the ALS Medical Protocols, up to the point of cardiopulmonary arrest.
    4. In the healthcare facility -
      1. A DNR order is valid if it is written in the order section of the patient chart (or on a transfer form) and is signed by a physician, registered nurse practitioner or physician assistant acting under physician authority. Copies of the order are valid.

    5. In a private home -
      1. A DNR form (See 9110 - Do Not Resuscitate (DNR) Guidelines - section D for examples for DNR forms you may encounter,) must be signed by the patient or proxy, the physician and a witness in order to be valid. No validation stamp or notarization is necessary and a legible copy is acceptable.

    6. If possible, the DNR order or copy should accompany the patient to the hospital. Pertinent documentation should be included on the ambulance report form for the run. In the event of confusion or questions regarding the DNR order, resuscitation should be initiated and a medical control physician should be consulted.
    7. Living wills should not be interpreted at the scene, but conveyed to the physicians in the receiving emergency department.
    8. Complete DNR guidelines for ambulance services operating within Hennepin County are found in 9110 - Do Not Resuscitate (DNR) Guidelines.

emSop, LLC

2040 - MEDICAL CONTROL AND COMMUNICATIONS FAILURE


    1. A medical control physician should be contacted as specified in these protocols.
    2. Whenever possible medical control should be obtained from the destination hospital requested by the patient.
    3. If the destination hospital is unable to provide medical control, paramedics may contact their service's default medical control hospital. Default medial control hospitals for each service are:
      1. Allina Health EMS - Abbott Northwestern Hospital
      2. Edina Fire Department - Fairview Southdale Hosital
      3. Hennepin EMS - Hennepin County Medical Center
      4. North Memorial Ambulance - North Memorial Medical Center
      5. Ridgeveiw Ambulance -
        • Ridgeveiw Medical Center - Waconia
        • Two Twelve Medical Center - Chaska

    4. Except for load-and-go situations with short transport times, any such delay in establishing medical control will be explained in a System Incident Report submitted by the paramedics to their medical director and to the Hennepin County Human Services and Public Health Department. This policy in no way precludes establishment of medical control at any time during the run to obtain physician advice or assistance.
    5. In the occurance of communication failure, paramedics may perform those orders outlined in the ALS Medical Protocols under "After Obtaining Verbal Orders" for patients with life-threatening or potentially life-threatening conditions.
    6. Initiation and performance of these orders must be in accordance with the paramedic's training and must be carried out as written in these Medical Protocols.
    7. Any instance of communications failure where procedures are carried out without a physician's verbal order must be reported in a System Incident Report within 48 hours to the paramedic's medical director and to the Hennepin County Human Services and Public Health Department.

emSop, LLC

2050 - MULTIPLE CASUALTY INCIDENTS (MCI)


    1. In special incidents with potental for multiple casualties, resources for the EMS system may be temporarily overwhelmed or extended to their limits.
    2. A system plan for EMS response to Multiple Casualty Incidents (MCIs) establishes a framework for coordinating resources during incidents requiring various ambulance providers, hospitals and public safety agencies to work together to optimize patient care and transportation with the given resources of the community. The goals of the system plan are to:
      • Recognize and maintain operations of ambulance providers, hospitals, and other agencies as close to normal as possible.
      • Utilize the incident command structures to allow flexibility for effective response to a variety of hazards most likely to occur within the county, including natural disaster, hazardous material exposure, urban fire, air crash, civil unrest or any incident with actual or potential multiple casualties.
      • Set system standards to aid individual agencies when developing policies and procedures.
      • As rapidly as possible transport patients to appropriate hospital(s).

    3. Ambulance services operating a Primary Service Area (PSA) in Hennepin County shall follow the regional Incident Response Plan (IRP) during a major incident or multiple casualty incident. Please see the latest version of the IRP for the definition of a Major Incident or Multiple Casualty Incident (MCI). Contact the Metro Regional System office for copies.

emSop, LLC

2060 - OXYGEN THERAPY - GENERAL GUIDELINE


    1. Oxygen therapy should be administered when indicated by specific protocol.
    2. When an EMS provider believes the patient will improve with oxygen therapy the following guidelines are applicable:
      1. For suspected smoke / CO inhalation, pneumothorax or sickle cell crisis, initiate high flow oxygen (≥ 10 lpm) via non-rebreather mask or BVM with appropriate airway management.
        • Titrate to maintain goal SpO2 of 100%.
      2. For critically ill or unconscious patients with suspected hypoxia, initiate high flow oxygen (≥ 10 lpm) via non-rebreather mask or BVM with appropriate airway management.
        • Titrate down to MAXIMUM SpO2 of 96% (Discontinue for SpO2 ≥ 97%)
      3. For patients with STEMI or CVA DO NOT initiate oxygen therapy if SpO2 > 92%
      4. For patients at risk for hypercapnic respiratory failure (COPD with chronic O2 use), use minimum flow necessary to achieve target SpO2 of 90%.
      5. For all other patients, use minimum flow necessary to achieve MAXIMUM SpO2 of 96% (Discontinue for SpO2 ≥ 97%)

    3. For pediatrics, if the patient is agitated use high flow blow-by O2.

emSop, LLC

2070 - PATIENT CONSENT AND REFUSAL OF CARE


To define and establish guidelines to be followed by prehospital care providers, when a patient refuses medical evaluation, treatment and/or transport.

Adult: Any person at or greater than the age of 18 years.

Minor: Any person who has not achieved the age of 18 years.

Minor not requireing parental consent: Any minor who -

  1. Has an emergency condition and parent is not available.
  2. Is or has been married.
  3. Has given birth.
  4. Is on active duty.
  5. Is separated from parents (with or without their consent) and financially independent.
  6. Is in need of pregnancy, venereal disease, or drug/alcohol related treatment (including rape.)

Request for Evaluation: A request for evaluation can be made by any individual for any reason. This request can be made by family members, friends, first responders, law enforcement personnel, or Ridgeview Ambulance personnel. All requests for evaluation will be honored by Ridgeview Ambulance Service and will include a complete medical assessment appropriate to the provider's level of care.

Emergency Condition: A condition or situation (including severe pain) in which an individual had an immediate need for medical attention, such that the absence of medical attention could place one's health (or unborn child's health) in jeopardy.

Competent: The patient is alert and oriented and has the capacity to understand the circumstances surrounding his/her illness or impairment and the risks associated with refusing medical evaluation, treatment and/or transport.

Refusing Care Against Medical Advice (AMA): A competent individual who is determined by pre-hospital providers to have an emergency condition, who has been advised of this condition and the risks/possible complications of refusing care, and still declines care.

Declining Treatment or Transportation: A competent individual (not minor) who is determined by pre-hospital providers to not have an "emergency condition" (as defined above,) who has been offered treatment and/or transportation with an explanation of the associated risks and benefits of this care and still declines treatment and/or transportation.

Transport Hold: An individual who is determined by law enforcement personnel or on-line medical control physician (health officer) to be in danger of harming himself/herself or others if not immediately restrained and needs transport to a medical facility for further evaluation.

  1. Any competent adult or minor not requiring parental consent, has the right to determine the course of his/her medical care, and thus is allowed to refuse care, provided the risks and potential complicaitons of refusing care have been explained.
  2. Any minor (except those not requiring parental consent) must have a parent or legal guardian (or responsible adult whom a parent/legal guardian has deliberately left the minor in the care of) present to refuse medical evaluation, treatment or transport.
  3. Refusal of care against medical advice or declining treatment/transportation should not be considered for patients who do not demonstrate competency. Competence may be impaired by mental illness, drug or alcohol intoxication, neurologic disease or injury, metabolic disorders or other injury/illness. Patients who have attempted suicide, verbalized suicide intent, or when other factors lead pre-hospital or law enforcement personnel to suspect suicidal intent, should not be regarded as competent.
  4. Any patient for whom a request for evaluation has been made, shall be offered medical evaluation, treatment and/or transport by pre-hospital providers. The patient, family, friends or first responders/law enforement personnel can make this request.

  1. If no request for medical evaluation has been identified by first responders/law enforcement and the responding ambulance is canceled prior to arrival the call is considered CANCELED or CANCELED EN-ROUTE.
  2. If when the responding ambulance arrives on the scene -

    1. Any / all involved persons should be offered evaluation by Ridgeview Ambulance Service personnel.
    2. If EMS personnel or first responders feel a patient warrants evaluation based on mechanism and / or symptoms, or if an evaluation is accepted, an EMS Run Report is completed for each individual who had an evaluation and the appropriate Run Disposition selected:

      1. Treated / Transported
      2. Treated / No Transport (AMA)
      3. Treated / No Transport (Per Protocol)

    3. Any additional individuals who decline evaluation should be entered onto a refusal log.
    4. If all involved persons decline evaluation, an EMS Run Report is completed for the event, and the event is considered Cancelled - Cancelled on Scene (No Patient Found). Documentation within the narrative should include pertinent information such as:

      1. Responding ambulance findings,
      2. Any Police or Fire personnel statements of their findings.

  3. If a competent adult or minor who does not require parental consent, refuses medical evaluation, treatment and/or transportation following an identified request for evaluation, pre-hospital personnel shall -
    1. Complete a thorough medical evaluation, if consented, which will include -
      1. Vital signs (if cooperative.)
      2. General appearance (e.g. appears comfortable, up walking, etc.)
      3. Mental status exam including :
        1. Alert (eyes open, awake.)
        2. Oriented to person, place, time.
        3. Speech (fluent, coherent, understandable with rational thought process.)

      4. Problem focused physical exam (if cooperative.)

    2. Advise the individual of your preliminary medical assessment.
    3. If an emergency condition is thought to exist -
      1. Advise the patient of the need for immediate treatment and/or transportation and the risks and potential complications of refusing, in the presence of a witness.
        1. Witnesses include :
          • Immediate family members
          • Legal guardian
          • Power of attorney
          • Friends
          • Law enforement personnel
          • Ridgeview Ambulance personnel

      2. To ensure understanding, have the patient verbalize the assessment and the risks or complications of refusal of care.
      3. Encourage consent for care using any available means (including family, friends, etc.)
      4. Complete the Against Medical Advice (AMA) form.
        • If patient refuses to sign, document this in the presence of a witness.

      5. Contact medical control for any refusal of care Against Medical Advice or for any concerns regarding competency or disposition.
        • Offer further discussion with on-line physician.

      6. Re-offer treatment/transportation and extend that offer to any time period after leaving the scene.
      7. Provide appropriate care and call back instructions sheet.

    4. If an emergency condition is thought not to exist -
      1. Offer treatment and/or transportation.
      2. Discuss the need for further evaluation, treatment or follow-up as indicated.
      3. Discuss the benefits of consenting to immediate treatment/transport and the risks and possible complications of declining.
      4. Complete an EMS Run Report and have patient sign form.
        • If patient refuses to sign, document this in the presence of a witness.

      5. Provide appropriate care and call back instruction sheet.
      6. Contact medical control if any doubts concerning competency or concerns regarding disposition.
      7. Offer treatment/trasnportation again and extend that offer to any time period after leaving the scene.

    5. If the patient is a minor (except those not requireing parental consent) -
      1. Determin if an emergency condition exists, if so treat/transport accordingly with implied consent -
        1. Minors cannot refuse necessary emergency care without the approval of a parent or legal guardian.
        2. Do not delay treatment/transport of emergency conditions in order to obtain parental consent.
        3. If parent or guardian refuses necessary treatment, and there are concerns about neglect, or abuse, have law enforcement respond and contact medical control for further orders.
        4. If advised by medical control, fill out and discuss AMA form as stated in adult policy (above.)

      2. If an emergency condition is thought not to exist and parent or guardian are not present at scene -
        1. Attempt to contact parent or legal guardian by phone.
        2. Discuss preliminary asessment and advise of any need for treatment/transport.
        3. Obtain verbal consent by phone and care for accordingly.
        4. Refusal of care cannot be given by phone. A parent, legal guardian, or apointed adult caregiver must be present on scene to refuse care.
        5. Document refusal per adult policy (above.)
        6. Contact medical control for any questions or if concerns arise regarding patient disposition or decision-making.

  4. If a patient is refusing care against medical advice or declining treatment/trasnport and is deemed not competent to refuse care -
    1. Ensure scene safety and utilize law enforcement if needed.
      • At no time shall ambulance personnel put themselves in danger by attempting to treat or transport a patient who refuses.

    2. If placed on transport hold by law enforement - (See 2140 - Patient Disposition - Transport Holds), transport to the appropriate hospital.
      1. If a patient has established hospital care, (appropriate for the nature of this event) they may be transported to that facitility. This optimizes continuity of care.
      2. If no established care, destination hospital per county policy.
      3. Concerns, questions or discrepancies regarding disposition and destination hospital should be discussed with medical control physician.

    3. If not on transport hold per law enforement and pre-hospital personnel determine the need for emergency transport hold, contact medical control for transport hold orders.
    4. In the case of rape, medical needs have priority over evidence collection and destination should be hospital of choice or closest. If there are no or only minor medical concerns, then transport per county policy.

  1. An EMS Run Report shall be completed on any patient for whom a request for evaluation has been made.
  2. For patients who refuse care against medical advice or decline treatment and/or transportation, this report must include -
    1. Vital signs and focused physical exam (if cooperative.)
    2. General appearane (e.g. appears comfortable, walking, sitting, etc.)
    3. Mental status exam, including -
      1. Alert (eyes open, awake.)
      2. Orientated to person, place, time.
      3. Speech (coherent, fluent, understandable with logical thought process.)
        • Document specific examples of abnormalities.

    4. The narrative portion of form should also contain -
      1. Plan of care offered to the patient.
      2. Reason for refusal.
      3. Any additional means attempted to influence a patients decision (e.g. family contacted.)
      4. Patients understanding of his/her medical condition and treatment plan.
      5. Potential risk/complications of refusal (including death if appropriate) discussed with patient.
      6. Any advice given to the patient (e.g. have family transport to emerency department, discuss the situation with your primary care physician, etc.)
      7. Patient signature or that of witness if refused.
      8. Any discussion with on-line medical control physician.

All patients for whom a request for evaluation has been made shall be offered medical evaluation and or transport by Ridgeveiw Ambulance personnel.

Criteria for refusing care -

  1. An adult (18 years old or over) or a minor not requireing parental consent.
  2. Is oriented to person, place, time and situation.
  3. Exhibits no evidence of altered mental status or drug/alcohol ingestion that impairs judgement.
  4. Understands the nature or their injury/illness, as well as the risks and possible consequences of refusing care.

Documentation Checklist

  • EXAM -
  • ▢Complete Vital Signs

    ▢Mental Status -

    • Alert and Orientated
    • Speech, Behavior
    • Gait

    ▢Focused physical exam

  • NARRATIVE SHOULD INCLUDE -
  • ▢Provider impression

    ▢Plan offered to patient.

    ▢Attempts to influence decision.

    ▢Patients verbal understanding of condition.

    ▢Potential risks/complications of refusal and patients verbalization of understanding

    ▢Any advice/forms given to patient

    ▢Patient signature or that of witness if refused.

    ▢Discussion with medical control.

emSop, LLC

2080 - PATIENT DISPOSITION – GENERAL GUIDELINES


    Determination of patient disposition should be based on the following criteria:

    1. Patient Preference – Patients should be transported to the hospital of their choice (or family's or physician's choice). Patient preference may be overridden by:
      1. The medical expertise of the Ambulance Medical Director,
      2. Restriction to specific hospitals.

    2. Medical Expertise – This authority may be represented by service specific policy, system policy, the On-Call System Medical Director, a medical control physician, a physician on-scene who has assumed total responsibility for the patient, or the paramedic providing patient care, (see 2160 - Physician Presence at the Emergency Scene.) Medical expertise shall override patient preference in three types of situations:
      1. Patient’s preference is unavailable (e.g. closed or unreachable due to weather). See www.hennepin.us/ems (NOTICE) for the Hennepin County EMS System Ambulance Diversion Policy.
      2. Patient’s preference is inappropriate (e.g. critical trauma patient transported to a facility not capable or equipped for the severity of the patient’s injuries.)
      3. Patient’s preference is suboptimal for presenting condition/complaint (the following examples are not inclusive):

emSop, LLC

2090 - PATIENT DISPOSITION – CARBON MONOXIDE POISONING


    1. For patients with symptoms of severe Carbon Monoxide (CO) poisoning, consider transport to a hospital that has a hyperbaric center.
    2. For pregnant patients who are transported with symptoms of CO poisoning, consider transport to a hospital that has a hyperbaric center for possible hyperbaric therapy.
    3. Hospitals in the Twin Cities Metro area with a hyperbaric center include:
      • Hennepin County Medical Center (HCMC)

    4. Signs and symptoms of severe CO exposure include:
      • History of loss of consciousness
      • Lethargy
      • Confusion
      • Disorientation
      • Seizures
      • Focal neurological deficits
      • Ischemic chest pain
      • New dysrhythmias
      • 12 Lead ECG changes
      • Hypotension

emSop, LLC

2100 - PATIENT DISPOSITION – MAJOR BURNS


    1. For patients with major burn injuries, consider transport to a hospital that has a burn unit.
    2. Hospitals in the Twin Cities Metro area with a burn unit include:
      • Hennepin County Medical Center (HCMC)
      • Regions Medical Center

    3. See the adult burns protocol 3120 - Burns or the the pediatric burns protocol 4120 - Burns.

emSop, LLC

2110 - PATIENT DISPOSITION – MAJOR TRAUMA


    1. Ground ambulances must immediately transport patients with compromised airways (unable to maintain an airway and ventilate) to the nearest designated trauma hospital.
      • If no designated trauma hospital exists within 30 minutes transport time, the patient must be transported to the closest hospital.

    2. In cases where a patient does not have a compromised airway, the ground ambulance must transport major trauma patients to a level I or level II trauma hospital within thirty minutes transport time.
      • If no level I or level II trauma hospital exists within 30 minutes transport time, the patient must be transported to the closest designated trauma hospital within 30 minutes transport time.
      • If no designated trauma hospital exists within 30 minutes transport time, the patient must be transported to the closest hospital.

    3. Critical trauma patient indicators for major trauma (as a result of a traumatic injury):
      1. Compromised airway.
      2. Signs of respiratory distress.
      3. Altered Level of Consciousness - less than "A" on the AVPU scale resulting from a traumatic event.
      4. Signs of shock or diminished perfusion.
      5. Severe burns.
      6. Other considerations:
        1. Severe multiple injuries (two or more systems) or severe single system injury.
        2. Cardiac or major vessel injuries resulting from blunt or penetrating trauma.
        3. Injuries with complications (e.g. shock, sepsis, respiratory failure, cardiac failure.)
        4. Severe facial injuries.
        5. Severe orthopedic injuries.
        6. Co-morbid factors (e.g. Age < 5 or > 55 years, cardiac or respiratory disease, insulin-dependent diabetes, morbid obesity.)
        7. Evidence of traumatic brain injury and/or spinal cord injury (e.g. new paralysis.)

      7. Paramedic provider impression is consistent with major trauma.

emSop, LLC

2120 - PATIENT DISPOSITION – STEMI


    Patients identified with acute myocardial infarctions, as evidenced by ST elevation (STEMIs), should receive timely transportation to a Level I Cardiac Care Facility per the EMS provider STEMI/Code AMI criteria. EMS Provider/STEMI Code AMI inclusion criteria includes:

    1. Patient presents with cardiac symptoms.
    2. 12-lead findings which are consistent with ST elevation greater than 1 mm in two or more contiguous leads.
    3. QRS complex is narrower than 0.12 seconds (3 small boxes.)
      • If wider than 0.12, you are unable to diagnose as STEMI.

    4. See www.hennepin.us/ems (NOTICE) for the Transport Policy for STEMI Patients.

emSop, LLC

2130 - PATIENT DISPOSITION – STROKE (CVA)


    Patients identified with acute cerebral vascular accident (CVA) per the Adult Stroke (CVA) protocol should receive timely transportation to the most appropriate designated acute stroke ready hospital, primary stroke center, or comprehensive stroke center.

emSop, LLC

2140 - PATIENT DISPOSITION – TRANSPORT HOLDS


    1. Paramedics may find themselves in a situation where a Transport Hold might be necessary to transport a patient to the emergency department.
    2. Elements of a Transport Hold (defined Minnesota Statute 253B.05 Emergency Admission Subd. 2):
      • A peace or health officer may take a person into custody and transport the person to a licensed physician or treatment facility if the officer has reason to believe, either through direct observation of the person's behavior, or upon reliable information of the person's recent behavior and knowledge of the person's past behavior or psychiatric treatment, that the person is mentally ill or developmentally disabled and in danger of injuring self or others if not immediately detained.
      • A peace or health officer or a person working under such officer’s supervision, may take a person who is believed to be chemically dependent or is intoxicated in public into custody and transport the person to a treatment facility. 253B.05 Emergency Admission Subd. 2.

    3. If Elements of a Transport Hold are present:
      1. Request a Transport Hold from a Peace/Health Officer,
      2. If the Peace/Health Officer does not provide a Transport Hold:
        1. Contact your service’s designated home medical control hospital and ask the Medical Control Physician to speak with the Peace/Health Officer,
        2. If the Peace/Health Officer does not provide a Transport Hold after speaking with the Medical Control Physician:
          • Do not transport,
          • AND
          • Leave the patient in the care of the Peace/Health Officer.

    4. All patients transported on a Transport Hold should be restrained during transport.
    5. For minors, follow statute regarding Health and Welfare Holds 260C.175 subdivision 1.

emSop, LLC

2150 - PATIENTS WITH WEAPONS


    If the patient has a weapon:

    1. Call law enforcement to assist if the crew has a safety concern.
    2. Notify the emergency department during your pre-arrival patient care report when transporting a patient known to have a weapon.

emSop, LLC

2160 - PHYSICIAN PRESENCE AT THE EMERGENCY SCENE


    1. Personal Physician -
      • If the patient's personal physician is present and wishes to assume responsibility for the patient's care:
        1. The paramedic should defer to the orders of the personal physician as long as those orders are appropriate and not in conflict with ALS Medical Protocols. Paramedics should establish medical control any time they are uncomfortable carrying out orders from a patient's physician.
        2. Orders given by the personal physician should be written on the EMS report form, the physician’s name documented legibly, and signed by the physician, if possible.

    2. System Medical Director -
      • If a system medical director or associate system medical director is present and wishes to assume responsibility for the patient’s care, the paramedic should defer to the orders of the system medical director or associate system medical director.

    3. Medical Control Physician -
      • If a medical control physician is present and wishes to assume responsibility for the patient’s care, the paramedic should defer to the orders of the medical control physician as long as those orders are appropriate and not in conflict with ALS Medical Protocols.

    4. Other Intervening Physician -
      1. If any other intervening physician wishes to assume responsibility for the patient:
        1. If medical control exists:
          • The intervening physician should be allowed to communicate with the medical control physician prior to the paramedics accepting orders. If there is any disagreement between the two physicians, the paramedics will follow the orders of the medical control physician and allow the physicians to continue their communication.

        2. If medical control does not exist:
          • The paramedics should relinquish responsibility for patient management if the physician meets the following two criteria:
            1. can show appropriate identification (or is known to the paramedics);
            2. agrees in advance to accompany the patient to the hospital (exception: majormultiple casualty incident);

          • The physician’s name should be documented legibly within the PCR and, if possible, have the physician sign the EMS report form assuming responsibility and verifying orders.

      2. In the case of multiple intervening physicians at the scene, the paramedics should request the physicians designate one physician to direct patient care.

    5. Any intervening physician not wishing to assume responsibility for care and not accompanying the patient to the hospital may be asked to assist the paramedics and/or act as a medical consultant to them and to the medical control physician.

emSop, LLC

3010 - AIRWAY MANAGEMENT


    1. Bag Valve Mask (BVM) – Consider an oropharyngeal or nasopharyngeal airway of appropriate size on all unconscious patients for initial airway maintenance.
    2. Endotracheal intubation – After endotracheal intubation, tube position must be confirmed using at least two methods, including continuous end-tidal carbon dioxide (CO2) detection and a second device or method to confirm tube placement.
    3. Alternate Advanced Airway Device – Services may use alternative advanced airway control devices (such as supraglottic airways) as specified by the ambulance service’s medical director. After placement of an alternate advanced airway device, place continuous end-tidal carbon dioxide (CO2) detection device on the tube.
    4. Pulse Oximetry – A pulse oximeter should be used for any patient with suspected hypoxemia, in respiratory distress, or whenever sedating medications are administered.

emSop, LLC

3020 - DIABETIC HYPOGLYCEMIC PATIENT REFUSAL OF TRANSPORT


    For all diabetic hypoglycemic patients refusing transport:

    1. The following criteria must be documented on your Patient Care Report (PCR) in order to leave a patient (without contacting medical control) experiencing a diabetic hypoglycemic emergency who refuses transport:
      1. Identifiable reason why the diabetic emergency happened.
      2. Blood sugar over 100 post treatment.
      3. Level of consciousness – awake, alert and oriented with a GCS = 15.
      4. Food intake – food available and able to eat or has eaten recently.
      5. Friend and/or family present and willing to stay with the patient.
      6. Discussion with the patient to contact physician for follow-up.
      7. Vital signs within normal limits:
        • MEDICAL CONTROL CONTACT IS REQUIRED IF:
          • Systolic blood pressure is less than 90, or greater than 180.
          • Heart rate is less than 50, or greater than 110.

      8. Offer of transport made.

    2. MEDICAL CONTROL CONTACT IS REQUIRED IF THE PATIENT MEETS ONE OR MORE OF THE FOLLOWING:
      • Is on an oral agent
      • Has a fever
      • Had a recent acute illness
      • Has a sign of a possible MI (atypical symptoms, dyspnea, shortness of breath, etc.)

    3. If unable to identify or document suspected reason for the diabetic emergency, a medical control physician must be contacted.

emSop, LLC

3030 - FIREGROUND FIRE FIGHTER REHABILITATION


    1. Establish communication with Incident Command or rehab division officer.
    2. Stage ambulance near rehab:
      • Consider egress and potential for additional incoming fire apparatus.

    3. Perform focused assessment including complete set of vital signs and temperature (if applicable):
      1. Consider 12-lead ECG.
      2. Consider Blood Glucose check.
      3. Consider transcutaneous CO measurement if available -
        • Administer high flow O2 immediately if concern for CO toxicity regardless of level or ability to measure.

    4. Immediate transport for:
      1. Symptoms of chest pain, severe SOB, altered mental status and syncope.
      2. Heart rate greater than 220 (minus patient’s age), systolic blood pressure less than 100, respiratory rate greater than 30, SpO2 less than 85%.
      3. Treatment for immediate transport:
        1. IV, O2, monitor, 12-lead ECG.
        2. Consider hydroxocobalamin (Cyanokit) administration if available.

    5. Begin active cooling/warming based on weather conditions.
    6. Provide oral rehydration 8 - 12 oz/10 minutes.
    7. Reassess the following after 10 minutes:
      1. Vital signs.
      2. Symptoms to assess for include:
        • Chest pain, dizziness, shortness of breath, weakness, nausea/vomiting, headache, cramps, change in behavior/speech, unsteady gait.

      3. If improving and asymptomatic, monitor until exit criteria met (see H):
        • Minimum 20 minute rest/rehydration time.
        • Offer transportation, if refused - document per service specific guidelines.

      4. If worsening or symptomatic, transport:
        • IV, O2, monitor, 12-lead ECG, blood glucose check.
        • Consider hydroxocobalamin (Cyanokit) administration if available.

    8. “May return to work” criteria (must meet/document all below):
      1. Offer of transport declined.
      2. Presence of normal speech/mental status and a steady gait.
      3. Normal vital signs:
        • Heart rate less than or equal to 110, respiratory rate less than or equal to 20, systolic blood pressure greater than 100, diastolic blood pressure less than 100, SpO2 greater than 95%, skin temp normal or measured less than 101.5o F, CO less than 10 (if applicable).

      4. Asymptomatic.
      5. EMS provider discretion may override and recommend “no return to work” despite meeting criteria.

emSop, LLC

3040 - INTRAVENOUS (IV) THERAPY


    Not every patient requires an IV. When indicated, intravenous fluid therapy should be administered in accordance with the following guidelines:

    1. For most patients requiring IV access, the paramedic has the option of either running fluids through the IV or capping the catheter with a saline lock. However, as specified in these Medical Protocols, IV fluids must always be hung in either situations:
      • When the administration of multiple IV medications is anticipated.
      • Whenever it is likely the patient will require fluid volume replacement.

    2. There should be no delay at the scene for IV attempts on major trauma patients or patients in shock; these IVs should be started during transport.
    3. Intraosseous infusion (IO) is a procedure for use in patients who are in critical condition when IV access is unobtainable.
    4. Paramedics may access a Peripherally Inserted Central catheter (or PIC line) if the patient has one in place as an alternate IV access point.
    5. Paramedics may access a central line if the patient is in cardiac arrest. The cap on the central line must be cleansed with alcohol and then 15-20 ml of fluid and blood must be aspirated from the central line before initiating IV fluids. If unable to aspirate, the central line should not be used.

emSop, LLC

3050 - PAIN MANAGEMENT


    To provide relief of pain when indicated. This protocol is NOT to be used in cases where the patient:

    • Has a systolic BP less than or equal to 90.
    • Has pain determined to be cardiac in origin (See 3230 - Ischemic Chest Pain).
    • Is in active labor.
    • Headache.
    • Low back pain (except as described below.)
    • Neck pain (except as described below.)
    • Any chronic pain (e.g. head, neck or back pain, fibromyalgia, abdominal or pelvic pain.)
    • Dental pain.

    Indications for use of Pain Management Protocol:

    1. Acute severe traumatic pain -
      • Neck or back pain from trauma and inability to ambulate from the incident.
      • Significant orthopedic injury. (Severe tenderness to palpation with swelling, bruising and/or deformity.)
      • Severe traumatic chest or abdominal pain with tenderness (ensure SBP > 90.)
      • Major burns (3120 - Burns.)

    2. Consider use for acute severe non-traumatic pain (e.g. abdominal or flank) with 2 or more of the following factors which tend to predict need for prompt treatment -
      • Less than 2 hours duration.
      • Increased heart rate and/or blood pressure.
      • Nausea and/or vomiting.
      • Writhing.
      • Described as severe (or 8 - 10 / 10 on pain scale.)

    3. Ischemic Chest pain should only be treated with opioids if there are ischemic changes on ECG and not responding to nitroglycerine. (3230 - Ischemic Chest Pain)
    4. Intubated patients with injury, painful condition or evidence of increasing discomfort (e.g. increasing BP or HR.)
    5. Active cancer or palliative care.

    For patients experiencing pain outside the above listed indications consider:

    • Symptomatic relief of nausea/vomiting if needed.
    • Advising them of the general concerns in the medical community about opioid use and that doctors are being very careful about which patients receive these addictive medications.
    • Inform them that we carry this type of medication for severe trauma such as broken bones and for certain medical situations that require immediate pain control such as heart attacks.
    • Acknowledge their pain and try to improve comfort.
    • Advise them that a doctor will need to evaluate them prior to administering pain medication.
    • Reassure the patient that the receiving facility will be notified of the need for prompt pain management assessment.
    • Consult medical control if questions.

    PROCEDURE

    1. Assess the patient’s pain on a 0-10 scale or other acceptable method for patients with difficulty communicating.
    2. Inform the patient that pain is an important diagnostic parameter and the goal of this protocol is to relieve suffering and not to totally eliminate pain.
    3. Administer one of the following medications:
      1. Morphine Sulfate IV -
        1. 2 mg up to 10 mg per dose IV/IO/IM/SQ.
          • Usual effective initial dose 0.1 mg/kg.
          • If using IV/IO route titrate in increments to patient response.

        2. If necessary administer additional dose(s) up to 5 mg IV/IO/IM/SQ every 5 to 10 minutes.
          • If using IV/IO route titrate in increments to patient response.

        3. No maximum total dose of Morphine Sulfate for adults.

      2. fentanyl -
        1. 50 - 100mcg IV/IO/IM/IN
          • Intranasal administration should not exceed 1 ml per nostril, (2 ml total fluid volume IN.)

        2. If necessary administer additional dose(s) of 50 mcg per dose every 10 minutes.
        3. Not to exceed total maximum cumulative dose of 200mcg.

      3. ketamine hydrochloride (Ketalar) -
        1. Pain must be -
          • Of a traumatic origin (non-cardiac),
          • Is moderate to severe,
          • Not responding to initial 10 mg Morphine Sufate or 100 mcg fentanyl administration,

          OR

          • If the patient has a morphine allergy,

        2. 0.1 mg/kg (not to exceed total dose of 10 mg) IV/IO/IM.
        3. May repeat x 1 after 10 minutes for persistent pain.

    4. Monitor the patient’s vital signs (including O2 saturation.) If respiratory depression or hypotension occurs after administration of Morphine Sulfate -
      1. Ventilate the patient as necessary.
      2. Administer naloxone hydrochloride (Narcan) -
        • 0.4 mg up to 2 mg IV/IO.

    5. Contact medical control physician for orders if:
      • The patient has a systolic BP less than or equal to 90.

    6. AFTER OBTAINING VERBAL ORDERS
      1. Consider initial or additional pain medication including benzodiazepines as appropriate:
      2. Monitor for respiratory depression when administering narcotics and benzodiazepines together.

emSop, LLC

3060 - SEDATION OF INTUBATED PATIENTS


    1. If the patient is ET intubated and becomes agitated from increased consciousness -
      1. Consider midazolam hydrochloride (Versed) -
        • 2 mg to 5 mg IV/IO/IM titrated.
        • Maintain a systolic BP of 100 or greater.

      2. Consider treatment of pain per 3050 - Pain Management.
      3. Consider additional Midazolam HCL (Versed) -
        • 2 mg to 5 mg IV/IO/IM titrated.
        • Maintain a systolic BP of 100 or greater.

    2. If the systolic BP is less than 100 -
      1. Consider ketamine hydrochloride (Ketalar) -
        • 1 mg/kg up to 2 mg/kg IV/IO.

        OR

        • 4 mg/kg up to 5 mg/kg IM.

      2. Ketamine is preferred in patients with low blood pressure.
      3. Should not be used for patients with penetrating eye injury.

emSop, LLC

3110 - AMPUTATIONS


    1. Patient:
      1. Control hemorrhage and cover stump with sterile dressing saturated with saline.
      2. Treat per 3140 - General Trauma / Traumatic Shock.
      3. Do not spend excessive time looking for the amputated part if the patient is unstable.

    2. Amputated Part:
      1. Wrap the amputated part in sterile gauze.
      2. Moisten with saline.
      3. Place in plastic bag.
      4. Place on top of ice, if available, or cold packs (do not freeze).

emSop, LLC

3120 - BURNS


    1. Consider direct transport to a burn center for major burns ( 2100 - Patient Disposition - Major Burns).
    2. Major burn criteria includes:
      • Partial-thickness burns greater than 10% of total body surface area.
      • Partial-thickness or third degree burns that involve the face, hands, feet, genitalia, perineum, or major joint.
      • Third degree burns in any age group.
      • Lightning injury and other electrical burns.
      • Chemical burns.
      • Inhalation injury.
      • Burn in any patients with preexisting medical disorders that could complicate management, prolong recovery, or affect mortality.

    3. For any significant burn:
      1. Begin oxygen therapy. Use positive pressure ventilatory assist as needed.
      2. Obtain IV access.

    4. If less than 20% of the body surface is burned:
      1. Apply sterile dressings and saturate with cool water (leave Gel-pack(s) in place if applied by first responders).
      2. Do not allow any burn patient to become chilled and begin shivering.

    5. If more than 20% of the body surface is burned:
      1. Remove any non-adherent burned clothing and cover the patient with a sterile sheet.
      2. Consider NS bolus:
        • 500 ml for patients 18 to 65.
        • 250 ml for patients greater than 65 or history of CHF.

      3. Do not cool down with water (exception: presence of smoldering clothes, articles or material adhering to skin that would continue the burning process, e.g., hot tar, etc.).
      4. Begin rapid transport.
      5. Consider direct transport to a burn center for major burns.
      6. Consider pain management - 3050 - Pain Management.

    6. Monitor the patient’s ECG after any electrical burn including a lightning strike.

emSop, LLC

3130 - CRUSH INJURIES


    1. Confirm prolonged entrapment (greater than one hour) of one or more full extremities by a crushing object (e.g. vehicle, building rubble, hanging in harness, self).
    2. If a distal extremity is accessible, assess sensation, motor function, skin color and distal pulses.
    3. For entrapments with potential extended scene times (>30min), contact your service for notification/activation of your service’s medical director(s).
    4. Pre-Extrication, if possible:
      1. Administer oxygen via mask if the situation allows.
      2. Obtain venous access with two large bore IV/IOs when possible and hang two 1000 ml Normal Saline bags.
        • Administer up to two liters of NS bolus followed by 500 ml/hr.

      3. Control pain per protocol - 3050 - Pain Management.
      4. Monitor the patient’s cardiac rhythm when situation allows.
      5. Immediately prior to extrication, consider Sodium Bicarbonate -
        • 2 mEq/Kg IV/IO up to 100 mEq.

      6. Extricate.

    5. Post-Extrication:
      1. Suspect hyperkalemia if T waves become peaked, QRS becomes prolonged (greater than 0.12 sec) or hypotension develops.
      2. Consider calcium chloride 10% -
        • 1 Gm IV/IO over 5 minutes for ventricular dysrhythmias.

      3. Consider additional Sodium Bicarbonate.
      4. Contact a medical control physician for persistent hyperkalemia or dysrhythmias.
      5. Post-extrication cardiac arrest – administer:
        1. calcium chloride 10% -
          • 2 Gm IV/IO push

        2. Sodium Bicarbonate -
          • 100mEq (2 amps) IV push

        3. Contact medical control for additional orders.

    6. NOTES:
      • Risk of crush syndrome is directly proportional to the amount of muscle tissue trapped - a single arm = low risk, both legs = high risk.
      • Crush is different than trapped – if the patient can feel and/or move the distal extremity easily the risk for crush syndrome is very low.

emSop, LLC

3140 - GENERAL TRAUMA/TRAUMATIC SHOCK


    1. Begin oxygen therapy.
    2. Spinal immobilization as appropriate.
    3. If the patient is intubated and begins to develop strong evidence of tension pneumothorax (i.e. increased airway resistance, hypotension and/or jugular vein distention) consider needle thoracostomy.
      • Perform needle thoracostomy at the second intercostal space, midclavicular line of affected side.
        • May be done without verbal orders if the patient is already intubated.
        • If the patient is NOT INTUBATED, consult a medical control physician immediately if a tension pneumothorax is suspected.

    4. Transport.
    5. Start an IV Normal Saline while en route on any patient with severe trauma. If systolic BP is less than 90, run the IV wide open until systolic BP reaches 90, then TKO.

    6. AFTER OBTAINING VERBAL ORDERS
      1. Consider needle thoracostomy if strong evidence of tension pneumothorax is present.

emSop, LLC

3150 - MAJOR TRAUMA


emSop, LLC

3160 - SPINAL PRECAUTIONS ALGORITHM


    Stage 1 Selective Spinal Precautions

    Stage 2 Selective Spinal Precautions

emSop, LLC

3210 - CARDIAC ARREST (ASYSTOLE / PEA)


    1. Complete a rapid scene survey observing for any indications or evidence that resuscitation should not be attempted (e.g., DNR orders or conditions incompatable with life.)
    2. If cardiac arrest occures in presence of the ambulance crew, assess the patient's cardiac rhythm and continue with the appropriate protocol.
    3. If the patient is in cardiac arrest upon arrival of the ambulance crew, institute or continue Basic Life Support:
      1. CPR: compressions 100/min, breaths 8 - 10/min. DO NOT OVER VENTILATE
      2. Impedance Threshold Device (ITD): Attach ITD to BVM and apply to patient within 30 seconds. You must maintain a tight, continuous, 2-handed face mask seal for the ITD to fuction properly. Use of ITD is service dependent.
      3. Reassess the patient's rhythm after every 5 cycles (2 minutes) of CPR. Limit interruptions in CPR during pulse/rhythm checks to less than 10 seconds for airway insertion and/or administration of medications

    4. Assess and confirm the patient's cardiac rhythm (check second lead to verify asystole,) immediately resume CPR.
    5. Review the most frequent causes for PEA, treat according to protocols if present:
      1. Hypovolemia - IV Fluids:
        • 500 ml for patients 18 to 65.
        • 250 ml for patients greater than 65 or history of CHF.

      2. Hypoxia - Ventilation and oxygenation.
      3. Hypothermia - Re-warming. See the 3510 - Hypothermia protocol.
      4. CONSIDER OBTAINING VERBAL ORDERS FOR:
        1. Acidosis - Sodium Bicarbonate.
        2. Hyperkalemia - calcium chloride 10% AND Sodium Bicarbonate.
        3. Tension pneumothorax - Needle chest decompression.
        4. Drug overdose - Intubation and specific antidote.
        5. Coronary thrombosis - 12-lead ECG.

      5. NO SPECIFIC PREHOSPITAL TREATEMENT FOR:
        1. Hypokalemia
        2. Cardiac tamponade
        3. Pulmonary embolism

    6. Secure the patient's airway during the pulse check. Continue CPR immediately then confirm tube placement by exam and confirmation device.
      • Once intubated with an advanced airway (ETT, i-gel, etc.) switch to continuous compressions with 10 breaths/min.

    7. Obtain IV access while providing two minutes of continuous CPR.
    8. During CPR, administer the following medication:
      1. epinephrine 1:10,000 -
        • 1 mg IV/IO every 3 - 5 minutes.

    9. Provide continuous CPR and reassess pulse and rhythm every two minutes.
    10. Continue CPR and contact medical control physician for further orders.
    11. AFTER OBTAINING VERBAL ORDERS
      1. If the cause of PEA is hypovolemia, consider requesting additional fluid orders.
      2. If there is no response, consider termination of resuscitative efforts.

emSop, LLC

3220 - CARDIAC ARREST (V-FIB AND PULSELESS V-TACH)


    1. If cardiac arrest occurs in the presence of the ambulance crew -
      1. Assess the patient’s cardiac rhythm and defibrillate x 1 if necessary.

    2. If the patient is in cardiac arrest on arrival of the ambulance crew, institute or continue Basic Life Support (BLS):
      1. CPR: Continuous compressions 100/min, breaths 8-10/min. DO NOT OVER VENTILATE.
      2. Impedance Threshold Device (ITD): Attach ITD to BVM and apply to patient within 30 seconds. You must maintain a tight, continuous, 2-handed face mask seal for the ITD to function properly. Use of ITD is service dependent.
      3. Reassess the patient’s rhythm after every 5 cycles (2 minutes) of CPR.
        • Limit interruptions in CPR during pulse/rhythm checks to less than 10 seconds for airway insertion and/or administration of medications.

    3. Assess and confirm Pulseless Ventricular Tachycardia/Ventricular Fibrillation then defibrillate x 1 if necessary using the following guidelines:
      1. Continue CPR while the defibrillator charges.
      2. Defibrillate at an intitial dose of 120 joules.
      3. Immediately resume CPR.

    4. Reassess the patient’s cardiac rhythm after 5 cycles (2 minutes) of CPR. If a shockable rhythm is present -
      1. Continue CPR while the defibrillator charges.
      2. Defibrillate at an escalated dose of 150 joules.
      3. Immediately resume CPR.

    5. Secure the patient’s airway during the pulse check. Confirm tube placement by exam and confirmation device. Monitor continuous End-Tidal (ETCO2).
      • Once intubated with an advanced airway (ETT, i-gel, etc.) switch to continuous compressions with 10 breaths per minute.

    6. Obtain IV access while providing two minutes of continuous CPR.
    7. The following pressor is to be given during CPR:
    8. Reassess and confirm Pulseless Ventricular Tachycardia/Ventricular Fibrillation then defibrillate x 1 if necessary using the following guidelines:
      1. Continue CPR while the defibrillator charges.
      2. Defibrillate at an escalated dose of 200 joules.
      3. Immediately resume CPR.

    9. The following antiarrhythmic is to be given during CPR:
      1. amiodarone hydrochloride (Cordarone) -
        • Initial dose of 300 mg IV/IO.
        • Repeat dose of 150 mg IV/IO once after four minutes of continuous CPR.

        OR

      2. lidocaine hydrochloride IV -
        • 1.0 to 1.5 mg/kg IV/IO first dose.
        • Repeat at 0.5 to 0.75 mg/kg IV/IO.
        • Maximum of 3 doses or 3 mg/kg.

    10. Reassess rhythm after 2 minutes of CPR; if shockable rhythm, continue CPR while defibrillator charges then defibrillate x 1 if necessary using the following guidelines:
      1. Continue CPR while the defibrillator charges.
      2. Defibrillate at a dose of 200 joules.
      3. Immediately resume CPR.

    11. Consider Magnesium Sulfate IV -
      • Loading dose 1 - 2 Gm IV/IO for Torsades de Pointes.

    12. Continue CPR and contact medical control physician for further orders.
    13. For patients who have received 2 unsuccessful defibrillation attempts (including AED prior to your arrival) - Transport to an ECMO capable facility (U of MN East Bank, Fairview Southdale, Abbott Northwestern or HCMC)

      1. Inclusion Criteria:

        1. Transport time to destination is approximately < 30 min OR total CPR time < 60 min
        2. Age 18 to 75,
        3. Independently living,
        4. V-fib/V-tach as initial rhythm (or AED shock)
        5. Presumed arrest is of cardiac etiology.
        6. Mechanical CPR device

      2. Continue usual Cardiac arrest management including

        1. Adequate airway management (prefer King or ETT)
        2. Vascular access (IV or IO.)
        3. First dose of antiarrhythmic (Amiodarone or Magnesium Sulfate.)
        4. Ensure First Responder help (two) and extra batteries for transport

      3. Provide EARLY communication:

        1. contact W-MRCC and notify you have a "Refractory V-fib Patient"
        2. Provide usual info (age, gender, pertinent clinical findings/medical history, ETA)

      4. Changes in condition (e.g. ROSC, PEA, asystole) should not change destination
      5. Limit epinephrine to TOTAL of 3mg IV/IO
      6. Administer 1 amp (50mEq) Sodium Bicarbonate IV while enroute
      7. If Inclusion Criteria are NOT met, provide usual Cardiac arrest care per protocol

    14. AFTER OBTAINING VERBAL ORDERS
      1. Consider additional doses of initial antiarrhythmic.
      2. Consider Sodium Bicarbonate for metabolic acidosis, tricyclic anti-depressant overdose or hyperkalemia.
      3. If there is no response to treatment consider termination of resuscitative efforts.

emSop, LLC

3230 - ISCHEMIC CHEST PAIN


    1. Obtain 12-Lead ECG.
    2. Administer:
      1. aspirin (ASA) -
        • 325 mg PO if the patient has no history of allergy to Aspirin (even in absence of chest pain.)

      2. nitroglycerin lingual spray -
        • 0.4 mg metered dose spray if the patient's systolic BP is greater than or equal to 100.
        • Consult with medical control physician if systolic BP is less than 100.
        • Check the BP immediately prior to and after administration of nitro.

    3. Establish IV access:
      1. If the patient has been loaded in the ambulance without IV access begin transport promptly.
      2. Establish IV access en route.

    4. Consider repeat/serial ECGs.
    5. If there is no pain relief and the patient’s systolic BP remains 100 or greater:
      1. Repeat nitro every five minutes.
      2. Recheck the patient’s BP before and after administration.
      3. If pain -
        • Persists after 3 nitro,
        • Systolic BP is greater than or equal to 100,
        • There are ischemic changes on ECG -
          1. May use Morphine Sulfate IV -
            • 2 to 10 mg titrated to obtain pain relief.
            • Continuing to administer nitro every 5 minutes.

          2. If the patient is allergic to Morphine Sulfate, may administer fentanyl -
            • 1 mcg/kg (up to 100 mcg per single dose) IV/IO.

    6. If the patient meets the inclusion criteria as an ST Elevation Myocardial Infarction (STEMI) patient as defined in the Metro Region STEMI Protocol the patient should be transported to a designated Level I Cardiac Center except as allowed in the protocol. The receiving facility should be notified as soon as possible that the patient is a STEMI patient by stating in your radio/phone report “STEMI ALERT.”

emSop, LLC

3240 - PULMONARY EDEMA


    1. Do not delay nitro to establish IV access.
    2. Keep the patient’s head elevated at all times.
    3. Begin oxygen therapy:
      1. If the patient’s respiratory distress is severe -
        1. Consider positive pressure ventilatory assistance if the patient is able to tolerate.
        2. Consider ET intubation if when -
          1. The patient's breathing is ineffective,
          2. OR

          3. The Glasgow Coma Score is less than 8.

    4. Monitor the ECG closely for dysrhythmias secondary to hypoxia.
    5. Give nitroglycerin lingual spray -
      1. 0.4 mg metered dose spray SL x 2 if the patient’s systolic BP is 140 or greater.
      2. Two minutes after the initial nitro dose, repeat nitroglycerin 0.4 mg metered dose spray SL x 1 if the patient still has signs of pulmonary edema AND the systolic BP remains 140 or greater.
      3. Five minutes after the second dose, repeat nitroglycerin 0.4 mg metered dose spray SL x 1 if the patient still has signs of pulmonary edema and the systolic BP is 140 or greater.

    6. Give aspirin (ASA) -
      1. 160 - 325 mg by mouth if the patient has no history of allergy.

    7. If the patient has no relief and their systolic BP remains 140 or greater:
      1. Repeat nitroglycerin every three to five minutes as necessary. Recheck the patient’s BP before and after administration

    8. Consider CPAP if two or more of the following are present:
      • Retractions or accessory muscle use.
      • Pulmonary edema.
      • Respiratory rate greater than 25/min.
      • SpO2 less than 92%.
        1. Administer CPAP (CPAP MODE) to achieve 11 - 12 cm H2O (15 LPM).
        2. Assess the patient’s response. If the patient’s condition worsens, (e.g. the patient becomes hypotensive, decreased SpO2) discontinue CPAP.
        3. If CPAP is initiated, continue to treat with medications as normal.

emSop, LLC

3250 - ROSC and CARDIAC COOLING


    For post-cardiac arrest Return of Spontaneous Circulation (ROSC):

    1. Initiate cardiac cooling measures if possible and if time allows.
    2. Patient must meet the following criteria:
      • Patient must be 18 years of age or older.
      • Initial arrest appears to be a primary cardiac arrest (non-traumatic in origin.)
      • Patient had ROSC in the field.
      • Patient is unconscious.
      • Patient has a BP greater than or equal to 90 systolic.

    3. Place standard chemical ice packs in the following locations:
      • One on the neck covering both carotid arteries.
      • One in each of the axillae.
      • One over each of the femoral vasculature in the groin.
      • Consider other cooling measures -
        • Turn on the ambulance AC in the patient compartment and direct air flow over the patient.
        • Removal of the patient’s clothes.

    4. Glucose check if possible and if time allows.
    5. Obtain a 12-lead ECG if possible and time allows.
    6. If an Impedance Threshold Device has been applied, remove with ROSC.
    7. Advise the emergency department personnel upon arrival that you have initiated the cooling process.

emSop, LLC

3260 - SYMPTOMATIC BRADYCARDIA


    1. Prepare for Transcutaneous Pacing.
      • Consider sedation.
      • Use without delay for high degree block (type II second-degree block or third-degree AV block.)

    2. Consider atropine sulfate IV -
      • 1.0 mg IV/IO while waiting for pacer.
      • May repeat atropine sulfate IV as necessary,
        • Not to exceed total maximum cumultive dose of 3 mg.

      • If atropine sulfate IV is ineffective begin pacing.

    3. Treat contributing causes.

emSop, LLC

3270 - TACHYCARDIA


    Tachycardia Flow Chart

emSop, LLC

3310 - ASTHMA ATTACK


    Asthma Flow Chart

    1. Administer BiLevel CPAP to achieve 11 - 12 cm H2O IPAP (16 LPM) with EPAP set to lowest possible pressure. If oxygenation status doesn't improve, increase EPAP to achieve desired SpO2.

emSop, LLC

3320 - COPD (ACUTE EXACERBATION)


    If the patient has a history of COPD and is symptomatic (presence of wheezing alone does not indicate COPD), en route to hospital, the following may be administered:

    1. Use a nasal cannula at 2 – 3 liters per minute initially. Oxygen may need to be increased if the patient’s oxygenation status worsens.
      • When a patient is already on oxygen, EMS oxygen therapy flow rate should not start at a lower rate than the patient’s current rate.

    2. Oxygen flow should be titrated to a target SpO2 of 90%.
      • Does not apply to patients on CPAP.

    3. May give nebulized treatment of:
    4. Consider CPAP if two or more of the following are present:
      • Retractions or accessory muscle use.
      • Pulmonary edema.
      • Respiratory rate greater than 25/min.
      • SpO2 less than 92%.
        1. Administer BiLevel CPAP to achieve 11 - 12 cm H2O IPAP (16 LPM) with EPAP set to lowest possible pressure. If oxygenation status doesn't improve, increase EPAP to achieve desired SpO2.
        2. Assess the patient’s response. If the patient’s condition worsens, (e.g. the patient becomes hypotensive, decreased SpO2) discontinue CPAP.
        3. If CPAP is initiated, continue to treat with medications as normal.

    5. AFTER OBTAINING VERBAL ORDERS
      1. Treatment based on patient history and physical exam findings.

emSop, LLC

3330 - KNOWN OUTBREAK OF TRANSMITTABLE RESPIRATORY ILLNESS (PATIENT IS BREATHING)


    To be used for patients with known or suspected transmittable respiratory illnesses in the presence of a known outbreak. This would include patients who have a febrile illness with cough. Examples include -

    • Severe Acute Respiratory Syndrome (SARS),
    • Tuberculosis,
    • Epidemic influenza,
    • Others not listed here,

    1. Protect yourself and crew with gowns, gloves and N95 mask/Powered Air Purifying Respirators (PAPR) and eye protection.
    2. Begin oxygen therapy by mask. If oxygen is not needed then place a surgical mask on the patient.
    3. For wheezing -
      1. albuterol sulfate Inhalation Solution, 0.083%
        • Metered dose inhaler (MDI) 2 puffs,
        • OR

        • Breath actuated nebulizer.

      2. May repeat selected dose method x 1.
      3. Additional treatment(s) may be given every 15 minutes thereafter as needed.

    4. Consider CPAP if two or more of the following are present:
      • Retractions or accessory muscle use.
      • Pulmonary edema.
      • Respiratory rate greater than 25/min.
      • SpO2 less than 92%.
        1. Administer CPAP (CPAP MODE) to achieve 11 - 12 cm H2O (15 LPM).
        2. Assess the patient’s response. If the patient’s condition worsens, (e.g. the patient becomes hypotensive, decreased SpO2) discontinue CPAP.
        3. Contact receiving hospital for isolation room preparations.

    5. For patients in moderate to severe respiratory distress, may administer on-site:
      1. terbutaline sulfate
        • 0.25 mg SC.

        OR

      2. epinephrine (1:1,000)
        • 0.5 mL IM.

    6. AFTER OBTAINING VERBAL ORDERS
      1. If not already given, consider terbutaline sulfate -
        • 0.25 mg SC.

      2. May repeat albuterol sulfate Inhalation Solution, 0.083% immediately for moderate to severe distress.

emSop, LLC

3340 - KNOWN OUTBREAK OF TRANSMITTABLE RESPIRATORY ILLNESS (PATIENT IS NOT BREATHING)


    To be used for patients with known or suspected transmittable respiratory illnesses in the presence of a known outbreak. This would include patients who have a febrile illness with cough. Examples include -

    • Severe Acute Respiratory Syndrome (SARS),
    • Tuberculosis,
    • Epidemic influenza,
    • Others not listed here,

    1. Protect yourself and crew with gowns, gloves and N95 mask/Powered Air Purifying Respirators (PAPR) and eye protection.
    2. Insert oral airway and begin positive pressure ventilation.
    3. Insert ET tube or other airway control device as authorized, as soon as possible. Use face shield (or Powered Air Purifying Respirator if wearing one) for your eye protection during intubation.
    4. May administer:
      1. terbutaline sulfate
        • 0.25 mg SC.

        OR

      2. epinephrine (1:1,000)
        • 0.5 mL IM.

    5. See the EMSRB website www.emsrb.state.mn.us (NOTICE) for the “EMS Exposure/Special Pathogen Situation Response Guide” for further information.

emSop, LLC

3350 - TENSION PNEUMOTHORAX


    1. Begin appropriate oxygen therapy. ET intubate for severe distress and/or ineffective breathing.
    2. Consult with a medical control physician immediately if a tension pneumothorax is suspected.
    3. AFTER OBTAINING VERBAL ORDERS
      1. Consider needle thoracostomy if there is strong evidence of a tension pneumothorax (i.e. increased respiratory distress, weak rapid pulse, cyanosis, hypotension, uneven chest wall movement and decreased lung sounds on affected side).
        • Perform a needle thoracostomy at the second intercostal space, midclavicular line of affected side.

      2. Treatment based on patient history and physical exam findings.

emSop, LLC

3410 - ANAPHYLAXIS / ALLERGIC REACTION


emSop, LLC

3420 - BEHAVIORAL EMERGENCIES


    1. Assess the severity of the patient’s agitation.
    2. Consider additional personnel to adequately and safely restrain the patient.
    3. SEVERE AGITATION
      1. If the patient is severely agitated and poses an immediate threat to himself/herself or others, consider giving one or both medications (may be mixed together in one syringe):
        1. midazolam hydrochloride (Versed) -
          • 5 mg IV/IO/IM

          AND/OR

        2. haloperidol (Haldol) -
          • 5 mg up to 10 mg, IV/IO/IM (dosage based on the patient’s age and/or weight).

      2. For continued agitation, consider contacting a medical control physician for further orders.
      3. AFTER OBTAINING VERBAL ORDERS
        1. Consider additional midazolam hydrochloride (Versed) -
          • 1 mg up to 5 mg IV/IO/IM.

    4. PROFOUND AGITATION
      1. If the patient is profoundly agitated with active physical violence to himself/herself or others evident, and usual chemical or physical restraints (section C) may not be appropriate or safely used, consider:
          • 5 mg/kg IM.
          • If IV already established, give 2 mg/kg IV/IO.

        1. DO NOT attempt to place an IV in a severely combative patient.

      2. If ketamine hydrochloride (Ketalar) is administered, rapidly move the patient to the ambulance and be prepared to provide:
        1. Respiratory support including suctioning, oxygen, and intubation.
        2. Monitoring of the airway for laryngospasm (presents as stridor, abrupt cyanosis/hypoxia early in sedation period). If laryngospasm occurs perform the following in sequence until the patient is ventilating, then support as needed:
          • Provide jaw thrust and oxygen.
          • Attempt Bag Valve Mask (BVM) ventilation.

        3. If hypersecretion is present -
          1. Consider atropine sulfate IV -
            • 0.1 mg up to 0.3 mg IV/IO.
            • 0.5 mg IM.

        4. If emergence of hallucinations/agitation after administration of Ketamine:

      3. Consider IV access once sedation occurs (if no IV access previously established and Ketamine given IM) then administer Normal Saline wide open up to 1 liters.
      4. Consider Sodium Bicarbonate -
        • 1 amp IV/IO push.

      5. Rapid transport at earliest opportunity.

emSop, LLC

3430 - CARBON MONOXIDE (CO) POISONING


emSop, LLC

3440 - CEREBRAL VASCULAR ACCIDENT (CVA)


    1. Assess ABCs and vital signs.
    2. Provide oxygen via nasal cannula ONLY if SpO2 < 92% and establish IV access.
    3. Check blood glucose level and treat if indicated.
    4. If B.E.F.A.S.T Stroke Scale (includes: Balance, Eyes/vision, Facial droop, Arm drift, Speech and Severe Headache) is positive (abnormal findings on the Scale), and:
      1. Symptom onset time < 8 hours:
        • Expedite transport,
        • Use “Stroke Alert” in radio report, and
        • Give time of symptom onset in clock time (e.g. 2:30 pm.)

      2. Symptom onset time > 8 hours:
        • State time of symptom onset (e.g. 2:30 pm) in your radio report.
        • DO NOT use “Stroke Alert” in radio report.

      3. Symptom onset time unknown (e.g. “wake up” stroke or patient is unable to communicate):
        • Expedite transport,
        • Use “Stroke Alert” in radio report,
        • State "unknown symptom onset time,” and
        • Document last known well time on your PCR

      4. Consider diversion if the difference in transport times to the requested hospital versus the closest hospital is greater than 30 minutes.

    5. Obtain ECG - 12 lead preferred.

emSop, LLC

3450 - CHEMICAL EYE INJURIES


    1. Attempt to remove the patient’s contact lenses, if present.
    2. Instill ophthalmic anesthetic (for example, tetracaine hydrochloride 0.5% (Altacaine).)
      • 1 to 2 drops into the affected eye(s).
      • May be repeated only once.

    3. Immediately and continuously flush the affected eye(s).
    4. Paramedics may insert Morgan lenses for irrigation if authorized.

emSop, LLC

3460 - CHOLINERGIC EXPOSURE


    Hennepin County EMS Units are equipped with Duodote (Atropine 2.1mg/Pralidoxime 600mg) kits primarily for treatment of responders. Chempack assets for mass casualty events can be activated via MRCC. Each Chempack treats up to 1000 patients using Mark 1 kits (same as Duodote but separate injectors for atropine and pralidoxime), Atropens (atropine for pediatric dosing), and diazepam auto- injectors for seizures.

    • Note – Chempack may contain Duodotes in the future and pediatric atro-pens may be eliminated.

    Common cholinergic agents include: Carbamates (carbofuran (Fursban), etc.), Nerve gas agents (sarin, tabun, VX, etc.), and Organophosphates (parathion, diazinon, malathion, chlorpyrifos (Dursban), etc.).

    1. Recognize a toxidrome: Miosis (small pupils) present in ALL significant exposures in association with at least two of the following:
      • Fasciculations
      • Respiratory distress
      • Increased secretions
      • Vomiting/diarrheas/incontinence
      • Seizure
      • Cardiovascular collapse

    2. Request CHEMPACK activation from MRCC if mass casualty incident.
    3. Wear appropriate personal protective equipment; DO NOT enter the hot zone.
    4. Assure appropriate patient decontamination measures if liquid or vapor exposures have occurred (in concert with fire department/HazMat).
    5. Assess the patient’s ABCs and begin oxygen therapy (when possible); intubate if needed (may have high airway resistance).
    6. Treat seizures with midazolam (or CHEMPACK – 10 mg diazepam auto-injectors).
    7. In cases of known organophosphate overdose/exposure or in a setting of a multiple casualty incident (MCI) with patients exhibiting this toxidrome:
      1. Administer atropine sulfate IV -
        • 2 mg up to 5 mg IV/IO/IM.
        • Repeat as necessary to control bronchial secretions.
        • OR

        • CHEMPACK - Atropine IM 2 mg auto-injectors.

      2. For patients with seizures, severe shortness of breath, and cardiovascular collapse administer:
        • 2 Duodote auto-injector kits (600 mg Pralidoxime, 2.1 mg Atropine) or 2 Mark 1 kits (CHEMPACK).

      3. Paramedics may administer one additional Duodote or Mark 1 kit after ten minutes if the patient continues to exhibit severe symptoms and no IV access has been established.
      4. Consider aggressive management of cardiac arrest if resources allow.

emSop, LLC

3470 - DIABETIC EMERGENCIES


    1. Determine blood glucose level.
    2. HYPERGLYCEMIA - If the patient’s blood glucose level is greater than 400 mg/dL and the patient is symptomatic:
      1. Obtain IV access.
      2. Give NS bolus -
        • 500 ml for patients age 18 to 65.
        • 250 ml for patients age who are greater than 65 or history of CHF.

      3. Transport

    3. HYPOGLYCEMIA - If blood glucose level is less than 60 mg/dL and the patient is symptomatic:
      1. If the patient is conscious give sugar:
        1. Dextrose IV -
          • 50 ml PO.

          OR

        2. oral glucose (Glutose) -
          • 80 Gm PO.

      2. If the patient is unable to take oral fluids due to an altered level of consciousness:
        1. Obtain IV access.
        2. Administer either:
          1. Dextrose IV -
            • 50 ml IV/IO.

            OR

          2. Glucagon -
            • 1 mg IM / IN if IV access is difficult or impossible to establish.
            • NOTE: For all IN doses that are ≤ 0.9 mL, add 0.1 mL to ensure full dose of medication is given.

      3. For adult patients who have experienced a hypoglycemic event and refuse medical transportation, see 3020 - Diabetic Hypoglycemic Patient Refusal of Transport.
      4. AFTER OBTAINING VERBAL ORDERS
        1. Consider transport of all patients on oral hypoglycemic agents or long-acting insulin.

emSop, LLC

3480 - DRUG OVERDOSE


    1. Begin oxygen therapy.
    2. Tricyclic overdoses requiring respiratory support should be ventilated with high flow O2 via bag-valve-mask device.
    3. For any patient with a respiratory rate less than eight, or a patient history of or physical findings consistent with opioid overdose -
      1. Assist the patient’s ventilation.
      2. Consider naloxone hydrochloride (Narcan) -
        • 0.4 mg up to 2 mg IV/IO/IM/IN.
        • NOTE: For all IN doses that are ≤ 0.9 mL, add 0.1 mL to ensure full dose of medication is given.
        • Due to the relatively short half-life of naloxone hydrochloride (Narcan), patients that respond favorably to naloxone (Narcan) administration should still be considered under the influence and transported on a peace/health officer hold (aka transport hold) regardless of their mental status and/or refusal of care.

    4. For all suspected tricyclic overdoses, monitor ECG.
    5. AFTER OBTAINING VERBAL ORDERS
      1. Consider additional naloxone hydrochloride (Narcan) -
        • Not to exceed total maximum cumulative dose of 10 mg IV/IO/IM.

      2. Consider Sodium Bicarbonate -
        • 50 mEq IV/IO for tricyclic ingestion.

      3. Consider Glucagon -
        • 1 mg IV/IO/IM/IN for known beta blocker overdose.
        • NOTE: For all IN doses that are ≤ 0.9 mL, add 0.1 mL to ensure full dose of medication is given.

      4. Consider calcium chloride 10% -
        • 1 Gm for known calcium channel blocker overdose with hypotension or bradycardia.

emSop, LLC

3490 - ENVIRONMENTAL HYPERTHERMIA


    1. Begin cooling measures.
    2. If the patient is confused or unconscious, start a Normal Saline IV.
    3. Give NS bolus -
      • 500 ml for patients age 18 to 65.
      • 250 ml for patients age who are greater than 65 or history of CHF.

    4. Transport lights and siren.
    5. Monitor ECG -
      • DO NOT delay transport to obtain ECG.

emSop, LLC

3500 - HYPERKALEMIA


    1. For patients with:
      1. Signs of hyperkalemia based on known EKG findings;
      2. Hemodynamic instability due to known or suspected hyperkalemia;
      3. Cardiac arrhythmia or instability due to known or suspected hyperkalemia;
      4. Patients at risk for hyperkalemia (renal failure, dialysis, or diabetic ketoacidosis); or
      5. Laboratory confirmed hyperkalemia.

    2. Begin oxygen therapy.
    3. Monitor the patient’s ECG rhythm for wide QRS complex.
    4. Administer continuous nebulized albuterol sulfate Inhalation Solution, 0.083%.
    5. Obtain IV/IO access.
    6. Contact a medical control physician.
    7. AFTER OBTAINING VERBAL ORDERS
      1. Consider calcium chloride 10% 10 ml (1 Gm) IV/IO or more if indicated, over 5 minutes.
      2. Consider Sodium Bicarbonate 50 mEq IV/IO.
      3. Other treatments based on the patient history and physical exam findings.

emSop, LLC

3510 - HYPOTHERMIA


    1. Standing orders for all hypothermic patients:
      1. Remove wet garments.
      2. Protect against further heat loss and wind chill (use blankets and insulating equipment).
      3. Maintain the patient in a horizontal position.
      4. Avoid rough movement and excess activity.
      5. Monitor the patient’s cardiac rhythm.
      6. Assess responsiveness, breathing and pulse.
      7. Do a pulse check for 30 to 45 seconds (clinical signs of death may be misleading).

    2. Pulse and breathing present:
      1. Begin oxygen therapy.
      2. Begin transport immediately.
      3. Obtain IV access in route.
      4. Monitor ECG.
      5. Rewarming:
        • Mild hypothermia (temperature greater than or equal to 92o F or if the patient is shivering) - Passive rewarming, active external rewarming.
        • Moderate hypothermia (temperature greater than or equal to 86o F to less than 92o F, or if patient is shivering) - Passive rewarming, active external rewarming to truncal areas only (neck, armpits, groin).
        • Severe hypothermia (temperature less than 86o F) - Transport for active internal rewarming.

    3. Pulse and breathing not present - Generally, CPR should not be initiated if the patient:
      1. Is known to have been submerged (head under water) in cold water for more than 90 minutes.
      2. Has obvious signs of death (e.g. decapitation, slippage of skin, animal predation).
      3. Is frozen (e.g. ice formation in the airway).
      4. Has a chest wall that is so stiff that compressions are impossible.

    4. For pulseless patients with or without an organized ECG rhythm who do not meet criteria in part C and resuscitation efforts are initiated:
      1. Begin CPR.
      2. For VF/Pulseless VT, defibrillate once as prescribed by current AHA ACLS guidelines. See 3220 - Cardiac Arrest (V_Fib and Pulseless V_Tach).
        • Withhold medication treatments and further shocks and transport immediately.

      3. Obtain IV/IO access.
      4. Warm packs should not be used.

    5. AFTER OBTAINING VERBAL ORDERS
      1. Paramedics may consider cardiac arrest drugs and defibrillation but they are usually not effective until hypothermia is corrected.

emSop, LLC

3520 - LABOR AND DELIVERY


    1. If imminent delivery is not present, transport the patient in the position of comfort, usually on the patient’s left side.
    2. If in question of imminent delivery, observe briefly, then transport unless delivery is in progress.
      • Be prepared to stop the ambulance if delivery occurs en route.

    3. If delivery is in progress:
      1. Assist delivery using clean technique.
      2. Suction the infant only if needed to clear obvious obstructions.
      3. Protect from heat loss.
      4. If no need for immediate resuscitation, wait 30-60 seconds then double clamp and cut the umbilical cord approximately 8-10 inches from the infant.
      5. Term infants (> 37weeks) who are crying (good respiratory effort) and have good muscle tone can be given to the mother to nurse with continued warming efforts and re- assessment.
        1. For all others see 4480 - Newborn Emergencies.

      6. Transport; do not wait for nor attempt delivery of the placenta.
      7. Closely observe the infant for signs and symptoms of distress and monitor the mother for excessive postpartum bleeding.
      8. If complication(s) arise, see 4480 - Newborn Emergencies.

emSop, LLC

3530 - OBSTETRIC COMPLICATIONS


    1. Begin oxygen therapy and administer high flow O2 by mask for any complications.
    2. Immediate transport for:
      • Prepartum or postpartum hemorrhage (moderate to heavy).
      • Limb presentation.
      • Prolapsed umbilical cord.
      • Known multiple fetuses.
      • Previous cesarean section.

    3. Start an IV Normal Saline in route.
    4. If the patient is hypotensive, position on the left side and/or push the uterus to the patient’s left side.
    5. For postpartum hemorrhage:
      1. Massage the uterus gently.

    6. For prolapsed umbilical cord:
      1. Place the mother in a position to minimize pressure on the cord (e.g. the knee-chest position or Trendelenburg).
      2. Insert a gloved finger into the vagina and hold the presenting part off of the umbilical cord.
      3. Do not touch or attempt to replace the umbilical cord.

    7. Suspected eclampsia (20 weeks gestation with hypertension, or up to 7 days postpartum) –
      1. If patient is seizing with no known history of epilepsy/seizure disorder, administer 4 Gm Magnesium Sulfate IV/IO over 10 minutes.
        • NOTE: Dilute Magnesium Sulfate so total fluid volume is 20 ml.

    8. For infant distress, see 4480 - Newborn Emergencies.
    9. Contact a medical control physician for further orders for any complication(s).

emSop, LLC

3540 - SEPSIS


    1. Consider sepsis if you suspect the patient has an infection plus two of the following:
      1. Systolic blood pressure less or equal to 100
      2. OR

      3. Respiratory rate greater than or equal to 22
      4. OR

      5. Altered mental status (e.g. GCS less than or equal to 14)

    2. If the patient meets sepsis criteria in A:
      1. Administer NS bolus -
        1. 500 ml for patients age 18 to 65.
        2. 250 ml for patients age who are greater than 65 or history of CHF.
        3. May repeat up to 30 ml/kg to treat hypotension.

      2. If positive for suspected sepsis -
        1. Notify the receiving facility as soon as possible.
        2. State clearly in your radio/phone report - “SEPSIS ALERT.”

emSop, LLC

3550 - SEVERE NAUSEA AND/OR VOMITING


    If the patient has severe nausea and/or vomiting:

    1. Obtain IV access.
    2. If over age 12, administer ondansetron (Zofran) -
      1. 4 mg slow IV/IO (over 1 - 2 minutes.)
        • OR 4 mg IM (if unable to start an IV.)

      2. May repeat ondansetron (Zofran) dose once.

    3. Consider administration of:
      1. Give NS bolus -
        1. 500 ml for patients age 18 to 65.
        2. 250 ml for patients age who are greater than 65 or history of CHF.

emSop, LLC

3560 - SHOCK (NON-TRAUMATIC)


    1. Begin oxygen therapy.
    2. Begin transport immediately.
    3. Start a Normal Saline IV en route to hospital.
    4. Give NS bolus -
      • 500 ml for patients age 18 to 65.
      • 250 ml for patients age who are greater than 65 or history of CHF.
        • Goal should be BP of 90-100 systolic or improvement of clinical indicators.

    5. AFTER OBTAINING VERBAL ORDERS
      1. Consider requesting additional fluid orders for volume loading for hypotension.

emSop, LLC

3570 - STATUS SEIZURES


    1. Position the patient to maintain an open airway.
    2. Begin oxygen therapy.
    3. If the seizure is ongoing greater than 5 minutes:
      1. Administer midazolam hydrochloride (Versed) -
        • 5 mg IV/IO/IN.
        • NOTE: For all IN doses that are ≤ 0.9 mL, add 0.1 mL to ensure full dose of medication is given.
        • 10 mg IM (if unable to start an IV.)
        • May repeat midazolam hydrochloride (Versed) dose x 1 after 3 minutes for persistent seizure.

    4. Be prepared to support respirations.
    5. Determine the patient’s blood glucose level -
    6. If seizure activity is suspected from eclampsia (20 weeks gestation with hypertension, or up to 7 days postpartum) -

emSop, LLC

4001 - GENERAL PROTOCOLS


    Age limits for pediatric patients must be flexible. For patients less than 13 years of age, pediatric orders should always apply. Between the ages of 13 and 18 judgment should be used, although the pediatric orders will usually apply. It is recognized that the exact age of a patient is not always known.

    1. Parents should be allowed to stay with children during the evaluation and transport, if appropriate. The parent's lap is usually the best place for the examination of a stable patient.
    2. Paramedics may follow dosage and equipment recommendations listed on the Broselow Tape.
    3. See 9150 - Pediatric Reference Chart.

emSop, LLC

4010 - AIRWAY MANAGEMENT


    1. Bag Valve Mask (BVM) – Consider an oropharyngeal or nasopharyngeal airway of appropriate size on all unconscious patients for initial airway maintenance.
    2. Endotracheal intubation – After endotracheal intubation, tube position must be confirmed using at least two methods, including continuous end-tidal carbon dioxide (CO2) detection and a second device or method to confirm tube placement.
    3. Alternate Advanced Airway Device – Services may use alternative advanced airway control devices (such as supraglottic airways) as specified by the ambulance service’s medical director. After placement of an alternate advanced airway device, place continuous end-tidal carbon dioxide (CO2) detection device on the tube.
    4. Pulse Oximetry – A pulse oximeter should be used for any patient with suspected hypoxemia, in respiratory distress, or whenever sedating medications are administered.

emSop, LLC

4020 - INTRAVENOUS (IV) THERAPY


    Not every patient requires an IV. When indicated, intravenous fluid therapy should be administered in accordance with the following guidelines:

    1. For most patients requiring IV access, the paramedic has the option of either running fluids through the IV or capping the catheter with a saline lock. However, as specified in these Medical Protocols, IV fluids must always be hung in either situations:
      • When the administration of multiple IV medications is anticipated.
      • Whenever it is likely the patient will require fluid volume replacement.

    2. There should be no delay at the scene for IV attempts on major trauma patients or patients in shock; these IVs should be started during transport.
    3. Intraosseous infusion (IO) is a procedure for use in patients who are in critical condition when IV access is unobtainable.
    4. Paramedics may access a Peripherally Inserted Central catheter (or PIC line) if the patient has one in place as an alternate IV access point.
    5. Paramedics may access a central line if the patient is in cardiac arrest. The cap on the central line must be cleansed with alcohol and then 15-20 ml of fluid and blood must be aspirated from the central line before initiating IV fluids. If unable to aspirate, the central line should not be used.

emSop, LLC

4030 - PAIN MANAGEMENT


    This protocol is to be used to provide relief of pain when indicated for pediatric patients. This protocol is NOT to be used in cases where the patient meets any of the following:

    • Is hypotensive (i.e. clinical signs of poor perfusion, capillary refill greater than two seconds.)
    • Complains of abdominal pain.
    • Has sustained a head injury.
    • Has pain determined to be cardiac in origin.
    • Is in active labor.
    • Headache
    • Low Back pain (except as described below.)
    • Neck pain (except as described below.)
    • Any chronic pain (e.g. head, neck or back pain, fibromyalgia, abdominal or pelvic pain.)
    • Dental pain.

    Indications for use of Pain Management Protocol:

    1. Acute severe traumatic pain -
      • Neck or back pain from trauma and inability to ambulate from the incident.
      • Significant orthopedic injury.(Severe tenderness to palpation with swelling, bruising and/or deformity)
      • Severe traumatic chest or abdominal pain with tenderness (ensure SBP > 90.)
      • Major burns (4120 - Burns).

    2. Consider use for acute severe non-traumatic pain (e.g. Kidney stone) with 2 or more of the following factors which tend to predict need for prompt treatment -
      • Less than 2 hours duration.
      • Increased heart rate and/or blood pressure.
      • Nausea and/or vomiting.
      • Writhing.
      • Described as severe (or 8 - 10 / 10 on pain scale.)

    3. Intubated patients with injury, painful condition or evidence of increasing discomfort (e.g. increasing BP or HR.)
    4. Active cancer or palliative care.

    For patients experiencing pain outside the above listed indications consider:

    • Symptomatic relief of nausea/vomiting if needed.
    • Advising them of the general concerns in the medical community about opioid use and that doctors are being very careful bout which patients receive these addictive medications.
    • Inform them that we carry this type of medication for severe trauma such as broken bones and for certain medical situations that require immediate pain control such as heart attacks.
    • Acknowledge their pain and try to improve comfort.
    • Advise them that a doctor will need to evaluate them prior to administering pain medication.
    • Reassure the patient that the receiving facility will be notified of the need for prompt pain management assessment.
    • Consult medical control if questions.

    PROCEDURE

    1. Assess the patient’s pain on 0 - 10 scale if possible or use other scale if necessary. See also 9100 - Pain Scales.
    2. Inform the patient and/or guardians that pain is an important diagnostic parameter and the goal of this protocol is to relieve suffering, not totally eliminate pain.
    3. Administer one of the following medications:
      1. Morphine Sulfate IV -
        1. 0.1 mg/kg IV/IM/SQ (Maximum dose of 5 mg.)

      2. fentanyl -
        1. 1 mcg/kg IV/IO/IM/IN (Maximum dose of 50 mcg.)
          • Intranasal administration should not exceed 1 ml per nostril, (2 ml total fluid volume IN.)
          • NOTE: For all IN doses that are ≤ 0.9 mL, add 0.1 mL to ensure full dose of medication is given.

      3. ketamine hydrochloride (Ketalar) -
        1. Pain must be -
          • Of a traumatic origin (non-cardiac),
          • Is moderate to severe,
          • Not responding to initial dose of Morphine Sulfate or fentanyl,

          OR

          • If the patient has a Morphine Sulfate allergy,

        2. 0.1 mg/kg (maximum dose 10 mg) IV/IO/IM.
        3. May repeat x 1 after 10 minutes for persistent pain.

      4. NOTE: Refer to pediatric reference (e.g., Broselow Tape) if assistance is needed with pediatric vital signs or drug dosage calculations.

    4. Monitor the patient’s vital signs (including O2 saturation.) If respiratory depression or hypotension occurs after administration of Morphine Sulfate -
      1. Ventilate the patient as necessary.
      2. Administer naloxone hydrochloride (Narcan) -
        • 0.01 mg/kg IV (Maximum dose of 0.4 mg.)

    5. AFTER OBTAINING VERBAL ORDERS
      1. Consider initial or additional pain medication as appropriate.

emSop, LLC

4110 - AMPUTATIONS


    1. Patient:
      1. Control hemorrhage and cover stump with sterile dressing saturated with saline.
      2. Treat as per protocol - 4500 - Shock.
      3. Do not spend excessive time looking for the amputated part if the patient is unstable.

    2. Amputated Part:
      1. Wrap the amputated part in sterile gauze.
      2. Moisten with saline.
      3. Place in plastic bag.
      4. Place on top of ice, if available, or cold packs (do not freeze).

emSop, LLC

4120 - BURNS


    1. Consider direct transport to a burn center for major burns ( 2100 - Patient Disposition - Major Burns.)
    2. Major burn criteria includes:
      • Partial-thickness burns greater than 10% of total body surface area.
      • Partial-thickness or third degree burns that involve the face, hands, feet, genitalia, perineum, or major joint.
      • Third degree burns in any age group.
      • Lightning injury and other electrical burns.
      • Chemical burns.
      • Inhalation injury.
      • Burn in any patients with preexisting medical disorders that could complicate management, prolong recovery, or affect mortality.

    3. For any significant burn:
      1. Begin oxygen therapy. Use positive pressure ventilatory assistance as needed.
      2. Obtain IV access.

    4. If less than 20% of the body surface is burned:
      1. Apply sterile dressings and saturate with cool water (leave Gel-pack(s) in place if applied by first responders).
      2. Do not allow any burn patient to become chilled and begin shivering.

    5. If more than 20% of the body surface is burned:
      1. Remove any non-adherent burned clothing and cover the patient with a sterile sheet.
      2. Give 20 mL/kg NS bolus.
      3. Do not cool down with water (exception: presence of smoldering clothes, articles or material adhering to skin that would continue the burning process, e.g., hot tar, etc.).
      4. Begin rapid transport and contact a medical control physician for further orders and destination decision.
      5. Consider direct transport to a burn center for major burns.
      6. Consider pain management per protocol ( 4030 - Pain Management.)
      7. Monitor the patient’s ECG after any electrical burn including a lightning strike.

emSop, LLC

4210 - CARDIAC ARREST (ASYSTOLE / PEA)


    1. Complete a rapid scene survey observing for any indications or any evidence that resuscitation should not be attempted (e.g., DNR orders or conditions incompatible with life).
    2. If cardiac arrest occurs in the presence of the ambulance crew, assess the patient’s cardiac rhythm and continue with the appropriate protocol.
    3. If the patient is in cardiac arrest on arrival of the ambulance crew:
      1. Institute or continue BLS.
      2. CPR: compressions 100/min, breaths 8-10/min. DO NOT OVER VENTILATE
      3. Reassess the patient’s rhythm after every 5 cycles (2 minutes) of CPR. Limit interruptions in CPR during pulse/rhythm checks to less than 10 seconds for airway insertion and/or administration of medications.

    4. Assess and confirm the patient’s cardiac rhythm, immediately resume CPR.
    5. Review the most frequent causes for PEA, treat according to protocols if present:
      1. Hypovolemia – fluids.
      2. Hypoxia – ventilation and oxygenation
      3. Hypothermia – re-warming, treat per 4470 - Environmental Hypothermia.
      4. Hypoglycemia – if blood sugar < 60, treat per 4460 - Hypoglycemia.
      5. CONSIDER OBTAINING VERBAL ORDERS FOR:
        1. Acidosis - Sodium Bicarbonate.
        2. Hyperkalemia - calcium chloride 10% & Sodium Bicarbonate.
        3. Tension pneumothorax - Needle chest decompression.
        4. Drug overdose - Intubation and specific antidote.
        5. Coronary thrombosis - 12-lead ECG.

      6. NO SPECIFIC PREHOSPITAL TREATEMENT FOR:
        1. Hypokalemia
        2. Cardiac tamponade
        3. Pulmonary embolism

    6. Secure the patient’s airway during the pulse check. Continue CPR immediately then confirm tube placement by exam and confirmation device.
    7. Obtain IV access while providing two minutes of continuous CPR.
    8. During CPR, administer the following medication:
      1. epinephrine 1:10,000 -
        • 0.01 mg/kg IV/IO every 3 - 5 min. (0.1 mL/kg)

    9. Provide continuous CPR and reassess, checking the patient’s pulse/rhythm every two minutes.
    10. Contact medical control physician for further orders.
    11. AFTER OBTAINING VERBAL ORDERS
      1. If no response consider termination of resuscitative efforts.

emSop, LLC

4220 - CARDIAC ARREST (V-FIB AND PULSELESS V-TACH)


    1. If cardiac arrest occurs in the presence of the ambulance crew -
      1. Assess the patient’s rhythm
      2. Defibrillate x 1 if necessary (energy rates as prescribed by current AHA ACLS guidelines; e.g., 2 J/kg.).

    2. If the patient is in cardiac arrest on arrival of the ambulance crew, institute or continue BLS:
      1. CPR: compressions 100/min, breaths 8-10/min. DO NOT OVER VENTILATE.
      2. Reassess the patient’s rhythm after every 5 cycles (2 minutes) of CPR.
        • Limit interruptions in CPR during pulse/rhythm checks to less than 10 seconds for airway insertion and/or administration of medications.

    3. Assess and confirm the patient’s cardiac rhythm, if a shockable rhythm is present then defibrillate x 1 using the following guidelines:
      1. Continue CPR while the defibrillator charges.
      2. Defibrillate x 1 (energy rates as prescribed by current AHA ACLS guidelines; e.g., 2 J/kg.).
      3. Immediately resume CPR.

    4. Secure the patient’s airway during the pulse check, then confirm tube placement by exam and confirmation device.
    5. Obtain IV access while providing two minutes of continuous CPR. Transport early if no readily accessible IV/IO access.
    6. The following pressor is to be given during CPR:
      • epinephrine 1:10,000 -
        • 0.01 mg/kg (0.1 mL/kg) every 3-5 min.

      • NOTE: Refer to pediatric reference (e.g., Broselow Tape) if assistance is needed with drug dosage calculations for pediatric patients.

    7. Reassess the patient’s cardiac rhythm after 5 cycles (2 minutes) of CPR, if a shockable rhythm is present then defibrillate x 1 using the following guidelines:
      1. Continue CPR while the defibrillator charges.
      2. Defibrillate x 1 (energy rates as prescribed by current AHA ACLS guidelines; e.g., 2 J/kg.).
      3. Immediately resume CPR.

    8. Consider:
      1. amiodarone hydrochloride (Cordarone) -
        • 5 mg/kg bolus IV/IO

        OR

      2. lidocaine hydrochloride IV -
        • 1 mg/kg bolus IV/IO.

        OR

      3. Magnesium Sulfate IV
        • 25 mg/kg up to 50 mg/kg IV (for Torsades de Pointes or hypomagnesemia.)
        • Maximum of 2 grams.

    9. If no response to treatment, consider termination of resuscitative efforts.

emSop, LLC

4230 - SYMPTOMATIC BRADYCARDIA


    1. Oxygenate and ventilate.
    2. If cardiorespiratory compromise is present and heart rate is less than 60 beats per minute:
      1. Begin chest compressions.
      2. If despite oxygenation and ventilation symptomatic bradycardia persists:
        1. epinephrine 1:10,000 -
          • 0.01 mg/kg IV/IO.
          • May repeat every 3 to 5 minutes at same dose.

        2. For heart block or vagel etiologies atropine sulfate IV -
          • 0.02 mg/kg (minimum dose 0.1 mg) IV/IO.
          • May repeat once.
          • Maximum total combined dose for the patient not to exceed 1 mg.

        3. Consider cardiac pacing.

      3. If pulseless arrest develops see 4210 - Cardiac Arrest (Asystole / PEA).

    3. Review the most frequent causes and treat according to protocols if present:
      1. Hypovolemia – fluids.
      2. Hypoxia – ventilation and oxygenation.
      3. Hypothermia – re-warming, treat per 4470 - Environmental Hypothermia.
      4. Hypoglycemia – if blood sugar < 60, treat per 4460 - Hypoglycemia.

emSop, LLC

4240 - TACHYCARDIAS (WITH PULSES)


    Includes:

    • Probable sinus tachycardia.
    • Probable ventricular tachycardia.
    • Probable supraventricular tachycardia.

    Assess and support the patient’s ABCs, provide oxygen and ventilation, and attach the cardiac monitor/defibrillator.

    1. PROBABLE SINUS TACHYCARDIA
    2. Probable sinus tachycardia is defined as a QRS duration normal for the patient’s age (approximately less than or equal to 0.08 sec). An infant’s heart rate is usually less than 220 bpm; a child’s heart rate is usually less than 180 bpm. If hemodynamically unstable:

      1. Continue to assess and support ABCs, monitor, and provide oxygen and ventilation as necessary.
      2. Search for and treat underlying cause.
        • Consider Normal Saline bolus 20 mL/kg IV/IO.

    3. PROBABLE VENTRICULAR TACHYCARDIA
    4. Probable ventricular tachycardia is defined as a QRS duration wide for the patient’s age (approximately greater than 0.08 sec). If hemodynamically unstable:

      1. Perform synchronized cardioversion:
        1. Energy rates as prescribed by current AHA ACLS guidelines:
          • 0.5-1.0 J/kg; if not effective, increase to 2 J/kg

        2. Use sedation if possible but do not delay cardioversion.

      2. May attempt adenosine IV -
        1. 0.1 mg/kg IV (Maximum first dose 6 mg) - if it does not delay electrical cardioversion.
        2. May double first dose and repeat once (Maximum second dose 12 mg).
        3. Use rapid bolus technique.

      3. AFTER OBTAINING VERBAL ORDERS
        1. Consider amiodarone hydrochloride (Cordarone) -
          • 5 mg/kg IV over 20-60 minutes.

    5. PROBABLE SUPRAVENTRICULAR TACHYCARDIA
    6. Probable supraventricular tachycardia is defined as a QRS duration normal for the patient’s age (approximately less than or equal to than 0.08 sec). An infant’s heart rate is usually greater than or equal to 220 bmp; a child’s heart rate is usually greater than or equal to 180 bpm. If hemodynamically unstable:

      1. Consider vagal maneuvers (no delays).
      2. If IV access is readily available give adenosine IV -
        1. 0.1 mg/kg IV (Maximum first dose 6 mg).
        2. May double first dose and repeat once (Maximum second dose 12 mg).
        3. Use rapid bolus technique.

      3. If IV access is not readily available perform synchronized cardioversion:
        1. Energy rates as prescribed by current AHA ACLS guidelines:
          • 0.5-1.0 J/kg; if not effective, increase to 2 J/kg

        2. Use sedation if possible but do not delay cardioversion.

      4. AFTER OBTAINING VERBAL ORDERS
        1. Consider amiodarone hydrochloride (Cordarone) -
          • 5 mg/kg IV over 20-60 minutes.

emSop, LLC

4310 - ASTHMA ATTACK (PATIENT IS BREATHING)


    1. Begin oxygen therapy.
    2. Move the patient to the ambulance and begin transport.
      • Asthma patients should always be transported to a hospital for monitoring and further treatment.

    3. Give nebulized medications:
      1. Medications need to be mixed together -
      2. May repeat as needed.

    4. Contact a MEDICAL CONTROL physician for patients with continued moderate-to-severe respiratory distress after two nebs.
      1. If no improvement after 2 nebs consider:
        1. terbutaline sulfate -
          • 0.01 mg/kg SC.
          • MAXIMUM DOSE - 0.25 mg.

          OR

        2. epinephrine 1:1,000 -
          • 0.01 mg/kg (0.01 ml/kg) SC.
          • MAXIMUM DOSE - 0.3 ml.
          • To be used in the field only if the patient’s condition is severe.

          AND

        3. Magnesium Sulfate IV -
          • 25 mg/kg IV/IO over 3 to 5 minutes. Dilute (any dose) to 10 ml, total volume and given over 10 min.
          • MAXIMUM DOSE - 2 Gm
          • If hypotensive response to magnesium sulfate -
            • Administer 20 mL/kg normal saline bolus.

    5. If the patient is unresponsive to other treatments and impending respiratory failure is evident consider advanced airway.

emSop, LLC

4320 - ASTHMA ATTACK (PATIENT IS NOT BREATHING)


    1. Insert an oral or nasal airway and begin positive pressure ventilation. Ventilate with a short inspiration: long expiration ratio at a rate of 8 - 10/min.
    2. Insert advanced airway.
    3. Administer -
      1. epinephrine 1:1,000 -
        • 0.01 mg/kg (1 mg/mL) IM.
        • MAXIMUM DOSE - 0.5 mg.

      2. Continuous in-line nebulizer:
        1. Medications need to mixed together -

    4. Perform manual exhalation.
    5. Start an IV/IO.
    6. Administer -
      1. Magnesium Sulfate IV -
        • 25 mg/kg IV/IO over 3 to 5 minutes. Dilute (any dose) to 10 ml, total volume and given over 10 min.
        • MAXIMUM DOSE - 2 Gm
        • If hypotensive response to magnesium sulfate -
          • Administer 20 mL/kg normal saline bolus.

emSop, LLC

4330 - CROUP AND EPIGLOTTITIS


    1. Keep the patient upright at all times when conscious.
    2. Begin oxygen therapy.
      • Remove the O2 mask if it is not well tolerated by the patient,
      • Or if O2 sats indicate no oxygen is needed.

    3. If the child is unconscious, position supine and begin ventilation.
    4. Place ECG leads.
    5. Transport early.
    6. For suspected croup consider -
      1. Nebulized epinephrine 1:1,000 -
        • Dosage - 5 mg (5 ml.)

        OR if unable to administer via neb -

      2. IM epinephrine 1:1,000 -
        • Dosage - 0.01 mg/kg (0.01 ml/kg) IM.

emSop, LLC

4340 - FOREIGN BODY AIRWAY OBSTRUCTION (FBAO)


    1. If the patient is making efforts to clear their airway without success, you may assist with careful back blows (slaps) and chest thrusts for infants (less than one year old), and abdominal thrusts for children (greater than or equal to one year old) per BCLS guidelines.
      • Synchronize with the patient's cough.
      • Avoid abdominal compressions in infants less than one year old.

    2. If the patient has lost consciousness, attempt to open the airway (use moderate extension and jaw-lift) and ventilate the patient with a bag-valve-mask (BVM). Reposition and attempt ventilation again if the initial attempt was unsuccessful. If ventilations are unsuccessful, perform standard obstructed airway maneuvers for an infant or child as appropriate.
      • Position an infant with the head dependent during back blows and chest compressions.

    3. Consider direct laryngoscopy and foreign body removal with Magill forceps.
    4. Attempt endotracheal intubation.
    5. Transport early.

emSop, LLC

4410 - ANAPHYLAXIS/ALLERGIC REACTION


emSop, LLC

4420 - BEHAVIORAL EMERGENCIES


    1. Assess the severity of the patient’s agitation.
    2. Consider additional personnel to adequately and safely restrain the patient.
    3. If the patient is agitated and not amenable to reassurance, verbal de-escalation, or physical restraints, and poses an immediate threat to himself/herself or others -
      1. ketamine hydrochloride (Ketalar)
        • 3 - 5 mg/kg IM.

    4. Once sedation occurs establish IV access -
      1. Consider Normal Saline 20 ml/kg.

    5. For continued agitation, consider contacting a medical control physician for further orders.

emSop, LLC

4430 - CHOLINERGIC EXPOSURE


    Hennepin County EMS Units are equipped with Duodote (Atropine 2.1mg/Pralidoxime 600mg) kits primarily for treatment of responders. Chempack assets for mass casualty events can be activated via MRCC. Each Chempack treats up to 1000 patients using Mark 1 kits (same as Duodote but separate injectors for atropine and pralidoxime), Atropens (atropine for pediatric dosing), and diazepam auto-injectors for seizures.

    • Note – Chempack may contain Duodotes in the future and pediatric atro-pens may be eliminated.

    Common cholinergic agents include: Carbamates (carbofuran (Fursban), etc.), Nerve gas agents (sarin, tabun, VX, etc.), and Organophosphates (parathion, diazinon, malathion, chlorpyrifos (Dursban), etc.).

    1. Recognize a toxidrome: Miosis (small pupils) present in ALL significant exposures, in association with at least two of the following:
      • Fasciculations
      • Respiratory distress
      • Increased secretions
      • Vomiting/diarrheas/incontinence
      • Seizure
      • Cardiovascular collapse

    2. Request CHEMPACK activation from MRCC if mass casualty incident.
    3. Wear appropriate personal protective equipment; DO NOT enter the hot zone.
    4. Assure appropriate patient decontamination measures if liquid or vapor exposures have occurred (in concert with fire department/HazMat.)
    5. Assess the patient’s ABCs and begin oxygen therapy if possible; intubate if needed (may have high airway resistance.)
    6. Treat seizure per protocol with midazolam (or CHEMPACK – Diazepam 10 mg auto injector IM only if > 25 kg.)
    7. In cases of known organophosphate overdose/exposure or in a setting of multiple casualty incident (MCI) with patients exhibiting this toxidrome:
      1. Administer atropine sulfate IV 0.1 mg/kg IV/IO/IM (up to 2 - 5 mg/dose); repeat as necessary to control bronchial secretions
        • CHEMPACK – may contain auto injectors appropriate for:
          • Infant < 6 months = 0.5 mg infant (blue)
          • Todler < 2years = 1mg (red)
          • > 2 years old = 2 mg (standard Duodote or Mark 1 kit)

      2. For patients with seizures, severe shortness of breath, and cardiovascular collapse administer Duodote auto-injector if available (or Mark 1 kit from CHEMPACK):
        • 2 - 10 years of age – 1 Duodote/Mark 1
        • > 10 years of age – 2 Duodote/Mark 1 kits per adult protocol

      3. Paramedics may administer one additional Duodote (or Mark 1) kit after ten minutes if the patient continues to exhibit severe symptoms and no IV access has been established. IV atropine is preferred in pediatric patients.

    8. Consider aggressive management of cardiac arrest if resources allow.

emSop, LLC

4440 - DRUG INGESTION OR OVERDOSE


    1. For any patient with -
      1. Respiratory rate less than eight,
      2. OR

      3. Has a history of opioid overdose,
      4. OR

      5. Has physical findings consistent with opioid overdose,
        1. Administer naloxone hydrochloride (Narcan) -
          • 0.1 mg/kg IV/IO/IM up to 2 mg.

        2. Due to the relatively short half-life of naloxone hydrochloride (Narcan), patients that respond favorably to naloxone hydrochloride (Narcan) administration should still be considered under the influence and transported on a peace/health officer hold (aka transport hold) regardless of their mental status and/or refusal of care.

      6. For all suspected tricyclic overdoses, monitor ECG.

    2. AFTER OBTAINING VERBAL ORDERS
      1. Consider additional naloxone hydrochloride (Narcan) -
        • 0.1 mg/kg IM/IV up to 2 mg.

      2. Consider Sodium Bicarbonate -
        • 1 mEq/kg IV/IO for tricyclic ingestions.

      3. Consider Glucagon -
        • 0.1 mg/kg IV/IO/IM/IN for known beta blocker overdose.
        • NOTE: For all IN doses that are ≤ 0.9 mL, add 0.1 mL to ensure full dose of medication is given.

      4. Consider calcium chloride 10% -
        • 20 mg/kg (0.2 mL/kg) for known calcium channel blocker overdose with hypotension or bradycardia.

emSop, LLC

4450 - ENVIRONMENTAL HYPERTHERMIA


    1. Begin cooling measures:
      1. Apply cool packs to head and truncal areas.
      2. Suspend cooling measures if shivering occurs.

    2. If the patient is confused or unconscious:
      1. Start a Normal Saline IV.
      2. Give a bolus of 20 mL/kg.
      3. Monitor ECG.

    3. Transport lights and siren.

emSop, LLC

4460 - HYPOGLYCEMIA


    1. Determine blood glucose level.
    2. If blood glucose < 60 mg/dL and the patient is symptomatic:
      1. If the patient is conscious, cooperative, and able to swallow effectively, give oral glucose therapy.
      2. If the patient is unable to take oral fluids due to an altered level of consciousness:
        1. Obtain IV access.
        2. Give dextrose:
        3. May give Glucagon 1 mg IM / IN if IV access is difficult or impossible to obtain.
          • NOTE: For all IN doses that are ≤ 0.9 mL, add 0.1 mL to ensure full dose of medication is given.

    3. A medical control physician must be contacted in any case where the patient experienced a hypoglycemic event and the parent or guardian refused medical transportation.

emSop, LLC

4470 - HYPOTHERMIA


    1. Standing orders for all hypothermic patients:
      1. Remove wet garments.
      2. Protect against further heat loss and wind chill (use blankets and insulating equipment.)
      3. Maintain the patient in a horizontal position.
      4. Avoid rough movement and excess activity.
      5. Monitor the patient’s cardiac rhythm.
      6. Assess responsiveness, breathing and pulse.
      7. Do a pulse check for 30-45 seconds (clinical signs of death may be misleading.)

    2. Pulse and breathing present:
      1. Begin oxygen therapy.
      2. Begin transport immediately.
      3. Obtain IV access en route.
      4. Monitor ECG.
      5. Rewarming:
        • Mild hypothermia (temperature greater than or equal to 92o F or if the patient is shivering) - Passive rewarming, active external rewarming.
        • Moderate hypothermia (temperature greater than or equal to 86o F to less than 92o F, or if patient is shivering) - Passive rewarming, active external rewarming to truncal areas only (neck, armpits, groin).
        • Severe hypothermia (temperature less than 86o F) - Transport for active internal rewarming.

    3. Pulse and breathing not present - Generally, CPR should not be initiated if the patient:
      1. Is known to have been submerged (head under water) in cold water for more than 90 minutes,
      2. Has obvious signs of death (e.g. decapitation, slippage of skin, animal predation),
      3. Is frozen (e.g. ice formation in the airway) or,
      4. Has a chest wall that is so stiff that compressions are impossible.

    4. For pulseless patients with or without an organized ECG rhythm who do not meet criteria in part C and resuscitation efforts are initiated:
      1. Begin CPR.
      2. For VF/Pulseless VT defibrillate once as prescribed by current AHA ACLS guidelines. 4220 - Cardiac Arrest (V_Fib and Pulseless V_Tach). Withhold medication treatments and further shocks and transport immediately.
      3. Obtain IV access and contact medical control physician en route.
      4. Warm packs SHOULD NOT be used.

    5. AFTER OBTAINING VERBAL ORDERS
      1. Paramedics may consider cardiac arrest drugs and defibrillation but they are usually not effective until hypothermia is corrected.

emSop, LLC

4480 - NEWBORN EMERGENCIES


    1. In all situations, minimize the newborn’s heat loss:
      1. Dry the newborn well.
      2. Increase environmental temperature.

    2. Suction the newborn only if needed to clear secretions or an obstruction:
      1. During or after delivery, suction the mouth and oropharynx first, then the nose.
      2. If meconium is present at birth, and the infant has poor muscle tone and inadequate respiratory effort, keep warm and provide ventilatory assistance and oxygenation as needed, including intubation and suction if the airway is obstructed.

    3. During the first minute warm the infant, position airway, clear secretions if needed, and dry and stimulate.
    4. Assess for apnea, gasping, or heart rate less then 100:
      1. If apneic, gasping, or heart rate less than 100, initiate positive pressure ventilation, monitor SpO2, and consider ECG monitoring.
      2. If labored breathing or persistent cyanosis, reposition airway and administer oxygen (less then 30% FiO2).

    5. Reassess heart rate:
      1. If less than 100: correct ventilation of increase oxygen.
      2. If less than 60: start chest compressions, increase oxygen to 100%, and intubate.
      3. Continue to reassess heart rate.

    6. If heart rate remains less then 60, administer epinephrine 1:10,000 (0.01 mg/kg) IV/IO.
    7. Transport early. Attempt to maintain body temperature and assure optimal ventilation and oxygenation.

emSop, LLC

4490 - SEVERE NAUSEA AND/OR VOMITING


    1. If the patient has severe nausea and/or vomiting:
      1. Obtain IV access.
      2. Administer ondansetron (Zofran) -
        • DOSE - 0.1 mg/kg up to a maximum of 4 mg IV/IM/IO.
        • If given IV administer slowly over 1-2 minutes.
        • May be repeated once after 10 minutes.

    2. Contact a medical control physician for further orders if needed.

emSop, LLC

4500 - SHOCK


    Signs/symptoms of shock include:

    • Cool skin
    • Poor capillary refill
    • Tachycardia
    • Weak peripheral pulses
    • Low BP
    • Altered mental status.

    1. Perform a primary survey.
    2. Perform a secondary survey while obtaining history.
    3. Begin oxygen therapy.
    4. Trauma Related Shock:
      1. Immobilize the patient’s head and spine as necessary.
      2. Begin transport prior to any other ALS intervention(s). Position the patient in the Trendelenburg position if the patient is hypotensive.
      3. Apply ECG leads after a quick-look to establish cardiac rhythm.
      4. IV Fluids:
        1. IV Normal Saline using a macrodrip infusion set.
        2. If IV access is not possible IO access.

      5. Fluids to achieve/maintain a systolic BP as per chart below -

    1. Non-Trauma Related Shock:
      1. Begin transport prior to any other ALS intervention(s). Position the patient in the Trendelenburg position if the patient is hypotensive.
      2. Apply ECG leads after a quick-look to establish cardiac rhythm.
      3. IV Fluids:
        1. IV Normal Saline using a macrodrip infusion set.
        2. If IV access is not possible IO access.
          • Recommended initial bolus 20 mL/kg.

emSop, LLC

4510 - STATUS SEIZURES


    1. Position the patient to maintain an open airway.
    2. Begin oxygen therapy.
    3. If the seizure is ongoing greater than five minutes administer:
      1. midazolam hydrochloride (Versed)
        • IM/IN -
          • 0.2 mg/kg up to 10 mg per dose.
          • NOTE: For all IN doses that are ≤ 0.9 mL, add 0.1 mL to ensure full dose of medication is given.

        • If IV/IO established prior to seizure -
          • 0.1 mg/kg up to 5 mg per dose.

        • May repeat Midazolam (Versed) dose x 1 after 5 minutes for persistent seizure.

    4. Be prepared to support respirations
    5. If blood glucose low - 4460 - Hypoglycemia.
    6. If patient is still seizing after two doses contact medical control.

emSop, LLC

9010 - ALS PROCEDURES


    • All BLS procedures (including oral and nasal airway insertion)
    • ECG monitoring/interpretation
    • Defibrillation
    • Synchronized cardioversion
    • Deactivation of Implantable Cardiac Defibrillators (ICD)
    • Airway adjunct insertion (advanced airway)
    • Direct laryngoscopy for foreign body removal using Magill forceps
    • Endotracheal suctioning
    • Peripheral IV insertion (including external jugular)
    • Administration of specified drugs by:
      • IV push technique
      • IM and SC injection
      • Oral and sublingual administration
      • Inhalation (includes nebulization)
      • Intraosseous infusion of IV fluids and drugs (adult and pediatric)

    • Direction of patient in Valsalva maneuver
    • Blood glucose measurement
    • Uterine massage
    • Transcutaneous pacing
    • Endotracheal intubation
    • Measurement of end - tidal CO2
    • Measurement of O2 saturation by pulse oximetry
    • Continuous Positive Airway Pressure (CPAP)
    • 12 - lead ECGs

emSop, LLC

9020 - TRAUMA TEAM ACTIVATION


    General Principals of Activation

    1. All TRAUMA TEAM MEMBERS in contact with the patient should wear personal protective equipment:
      • Gowns
      • Gloves
      • Masks to include eye shields

    2. Only those designated should speak to the patient.
    3. Appropriate victim exposure must be achieved. Everyone must be vigilant to keep doors closed in order to maintain privacy.
    4. Two large bore IV's (or an IO) will be placed on all adult trauma patients and one largest possible IV (or an IO) will be initiated on all pediatric patients.
    5. If gun shot or criminal injury noted through clothing, avoid cutting this area of clothing in order to preserve as much of the evidence as possible. Save all clothing for proper collection in ED.

    Notification

    1. EMS identifies a patient meeting criteria for a TRAUMA TEAM ACTIVATION.
    2. EMS calls the ED on PATIENT INFORMATION and relays the following information:
      • "RED PATIENT - TRAUMA TEAM ACTIVATION"
      • Provide a report with:
        • Rig Number
        • ETA
        • TTA CODE T# as described below-
        • Patient Name
        • DOB
        • Other Emergent Special Needs

    Trauma Team Activation Criteria

    M. Herold MD - 14 October 2019

    1. EMS relays to dispatch patient is a TRAUMA TEAM ACTIVATION, TTA CODE T#, as well as ETA to ED.
    2. Upon arrival in ED:
      1. Give report following "TTA TIMEOUT" procedure (Mechanism, Injuries, Symptoms with Vitals/GCS, Treatment, Questions).
      2. Transfer patient from EMS stretcher to ED bed.
      3. Assist with patient care as directed.
      4. Prepare ambulance and equipment for potential transfer to another facility.

emSop, LLC

9030 - AUTOVENT 3000


The LSP Automatic Ventilator (AutoVent 3000) timed-cycled, constant-flow, gas-powered ventilator offers controlled ventilation at 8 to 20 breaths per minute. The attached Patient Valve Assembly allows a patient to draw supplemental gas flow (up to 36 LPM) with spontaneous effort. Designed for transport and emergency medical use, the AutoVent 3000 delivers from 200 to 1200 mL in volume and flow rates from 12 to 36 liters per minute. Operating power is obtained from standard 50 psi source gas.

The intended use is for patients that are intubated for reasons unrelated to primary cardiopulmonary problems. It can replace manual Bag-Valve-Mask ventilation and can be attended to by non-RT personnel as appropriate.

  1. Recommended by the American Heart Association over bag-mask ventilation.
  2. Gastric insufflation significantly reduced with non-intubated patients due to lower inspiratory pressures.
  3. Consistent minute ventilation maintained throughout patient movement and transport.
  4. Uniform ventilation and oxygenation during chest compressions.
  5. Asynchronous ventilation-to-compression ratios.
  6. Pediatric and adult settings.
  7. Ease of training and application of use.
  8. Allows for patient spontaneous breathing (an effort of -2cm H2O will activate the demand valve).

  1. Respiratory / cardiac arrest.
  2. Patients able to tolerate an advanced airway.
  3. Patients in need of ventilatory assistance.
  4. Patients with tracheostomy tubes in need of ventilatory assistance.

  1. Not intended for use in patients less than 20 Kg (44 lbs).
  2. Patients with respiratory failure due to primary cardio-pulmonary problems, for example:
    1. Acute Respiratory Distress Syndrome (ARDS).
    2. Congestive Heart Failure (CHF).
    3. Chronic Obstructive Pulmonary Disease (COPD).
    4. Pneumonia
    5. Other pulmonary process with active, or potential, ventilatory difficulties.

  1. Set the inspiratory time control knob to the desired adult or pediatric position. Rotate the control knob to either position until it is against the end stop.
  2. Set the tidal volume:
    • Adult(s) - 6 to 8 mL/kg - sufficient to produce chest rise.
    • Pediatrics - Use only the force and tidal volume needed to just make the chest rise visably; avoid delivering excessive ventilation during cardiac arrest.

  3. Set the BPM control knob to the desired setting.
  4. Test device by occluding delivery port to confirm high pressure alarm is functioning. Audiable alarm and visual pop up will occure.
  5. Use on patients with an endotracheal tube / KING or tracheostomy tube in place: after initial control module settings have been made, connect the patient valve assembly directly to the advanced airway adapter (15 mm inside diameter / 22 mm outside diameter dimensions allow this connection).


Autovent 3000 Troubleshooting Guide

AUTOVENT 3000
					Troubleshooting Guide Table

AUTOVENT 3000 Troubleshooting Guide

emSop, LLC

9040 - CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP)


    Continuous Positive Airway Pressure has been shown to rapidly improve vital signs, gas exchange, and the work of breathing, decrease the sense of dyspnea, and decrease the need for endotracheal intubation in patients who suffer respiratory distress from asthma, COPD, pulmonary edema, CHF, and pneumonia. In patients with CHF, CPAP improves hemodynamics by reducing preload and afterload.

    Any patient who is complaining of shortness of breath for reasons other than trauma and:

    • Is awake and able to follow commands.
    • Is over 12 years old and is able to fit the CPAP mask.
    • Has the ability to maintain an open airway.
    • A respiratory rate greater than 25 breaths per minute.
    • Has a systolic blood pressure above 100mmHg.
    • Uses accessory muscles during respirations.
    • Sign and Symptoms consistent with COPD, pulmonary edema/CHF.

    • Patient is in respiratory or cardiac arrest.
    • Patients suspected of having a pneumothorax (unequal breath sounds).
    • Patients at risk for vomiting.
    • Patient has a tracheostomy.

    • Use care if patient:
      • Has impaired mental status and is not able to cooperate with the procedure.
      • Has failed at past attempts at noninvasive ventilation.
      • Has active upper GI bleeding or history of recent gastric surgery.
      • Complains of nausea or vomiting.
      • Has inadequate respiratory effort.
      • Has excessive secretions.
      • Has a facial deformity that prevents the use of CPAP.

    • If utilizing CPAP with a portable O2 tank, pay particular attention to oxygen levels as small tanks can deplete quickly. When in the ambulance it is preferable to utilize the on-board oxygen.

    1. EXPLAIN THE PROCEDURE TO THE PATIENT.
    2. Ensure adequate oxygen supply to ventilation device (100%).
    3. Place the patient on continuous pulse Oximetry.
    4. Place the delivery device over the mouth and nose.
    5. Secure the mask with provided straps or other provided devices.
    6. Use in CPAP MODE only at 11 - 12 cm H2O (15 LPM).
    7. Check for air leaks.
    8. Monitor and document the patient’s respiratory response to treatment.
    9. Monitor vital signs at least every 5 minutes. CPAP can cause BP to drop.
    10. Monitor LOC closely. Worsening LOC indicates impending respiratory arrest. Be prepared to discontinue CPAP and assist ventilations.
    11. Monitor and document the patient’s respiratory response to treatment.
    12. Continue to coach patient to keep mask in place and readjust as needed.
    13. If respiratory status deteriorates, remove device and assist ventilations as needed.

    1. CPAP therapy needs to be continuous and should not be removed unless the patient can not tolerate the mask or experiences continued or worsening respiratory failure.
    2. Consider assisting ventilations manually if the patient is removed from CPAP therapy.
    3. CPAP may be discontinued if patient improves dramatically but be prepared to reinstitute CPAP is needed.

    • CPAP should not be used in children under 12 years of age.

    • Bronchodilator nebulization may be placed in-line with CPAP circuit.
    • Do not remove CPAP until hospital therapy is ready to be placed on patient.
    • Most patients will improve in 5-10 minutes. If no improvement within this time, consider assisting ventilations manually.
    • Watch patient for gastric distention. Be prepared for vomiting.
    • CPAP does not violate DNR Order.
    • Request ALS intercept if patient condition does not improve.

emSop, LLC

9050 - TOURNIQUET FOR SEVERE HEMORRHAGE


    1. Indications :
      1. Failure to stop bleeding with direct pressure or pressure dressing.
      2. Injury does not allow for hemorrhage control with pressure.
      3. Significant extremity hemorrhage in the face of any or all:
        • Need for airway management
        • Need for ventilator support
        • Circulatory shock
        • Need for other emergent interventions or assessment
        • Bleeding from multiple locations

      4. Impaled foreign body with ongoing extremity bleeding.
      5. Under fire or other dangerous situation for responding caregivers requiring immediate evacuation.
      6. Total darkness or other adverse environmental factors.
      7. Mass casualty, number of casualties exceeds ability to provide optimal care.

    2. Tourniquet Application :
      1. For severe bleeding associated with limb amputation or signs of shock with other exsanguinating hemorrhage, skip to 4 (apply tourniquet).
      2. Attempt to control bleeding with direct pressure or application of pressure dressing.
      3. If profuse bleeding persists after 5 min or unable to maintain pressure due to other patient care needs, apply a tourniquet (a commercial is preferred over an improvised tourniquet, but an improvised tourniquet is allowable if a commercial tourniquet is not available)
      4. Apply to appropriate extremity proximal to bleeding site over the humerus or femur only:
        1. Tighten the self-adhering strap.
        2. Tighten the windlass to loss of distal pulse.
        3. Secure windlass in place.

      5. Record time of application, preferably on extremity skin, or on tourniquet (if appropriate.)

    3. Specify site and patient ID if multiple patients or sites.
      1. Do not cover tourniquet unless risk of cold or environmental injury .
      2. At 30 min of tourniquet time, reassess for removal: • If shock, clinically unstable, limited personnel/resources or amputated extremity, DO NOT remove, otherwise, apply pressure dressing and loosen tourniquet (leave in place). If re-bleeding occurs tighten to stop bleeding
      3. Notify receiving healthcare personnel of tourniquet application time and location.

emSop, LLC

9060 - DIFFICULT INTUBATION - GUM-ELASTIC BOUGIE


The ENDOTRACHEAL TUBE INTRODUCER (ETTI - aka bougie or Eschmann) is a semi-rigid device used to facilitate oral tracheal intubation. It has a "hockey stick" end that eases insertion into the trachea even with sub-optimal visualization. The endotracheal tube is then passed over the ETTI into the trachea.

Indications :

Incomplete visualization of the glotic opening during laryngoscopy for endotracheal intubation.

Contraindications :

Not to be used with endotracheal tubes less than 5.5 mm diameter.

Precautions :

Excessive force or passage beyond the carina may result in soft tissue damage or rupture of the bronchus.

  1. Prepare for intubation per protocol, including preoxygenation, optimize positioning, suction & confirmation devices ready, etc....
    1. Lubricate ETTI with water-soluble jelly for dry oral pharynx as needed.

  2. Perform laryngoscopy :
    1. If no identifiable landmarks -
      1. Suction / remove foreign matter if present.
      2. Reposition laryngoscope.
      3. Attempt BURP maneuver.
      4. Consider immediate KING Airway placement versus reattemp after 30 to 60 seconds of BVM ventilation, then place KING Airway.

    2. If partial view of glotic opening -
      1. Consider suction, reposition, BURP as above.
      2. Use ETTI (see below.)

    3. If complete visualization -
      1. Pass ET tube on attempt per routine intubation protocol.

  3. Use of ETTI for partial visualization of glotic opening -
    1. Maintain glotic visualization with laryngoscope.
    2. Pass ETTI through cords (if visable) or under epiglottis above arytenoids.
    3. Note "clicks" as tip hits tracheal rings.
    4. Advance to point of slight resistance when tip touches carina.
      1. If no resistance is felt and depth is significantly past the black "lip line" marker -
      2. OR

      3. If no "clicks" felt -
      4. The introducer is in the esophagus.

    5. Have assistant slide the ET tube over the introducer until the far end of the introducer is through the ET tube. Assistant then stabilizes the introducer and intubater takes the ET tube and continues passing it through the cords. Maintain laryngoscopic visualization while advancing the ET tube to appropriate depth.
      1. Rotate ET tube counter-clockwise 90o if slight resistance is noted.

    6. Inflate cuff when intubator confirms complete insertion of ET tube.
    7. Stablize ET tube while withdrawing introducer.
    8. Remove laryngoscope.
    9. Confirm tube placement with auscultation, ETCO2, SaO2, aspiration device and vapor in tube.
    10. Secure ET tube in place.

emSop, LLC

9070 - ResQPOD


The Res-Q-POD is a single use device that enhances circulation during cardiopulmonary resuscitation by selectively impeding the inflow of respiratory gases during the recoil phase of chest compressions.

Indications :

  1. Cardiac Arrest

Contraindications :

  1. Less than or appearing less than 12 years old and/or 100 pounds.
  2. Any patient with a pulse and/or spontaneous respirations.

  1. Select appropriate airway adjuct (BVM, King Airway, ETT.)
  2. Use timing light with advanced airway (small red switch) during continuous CPR.
  3. While performing CPR - place Res-Q-POD between the airway adjunct and ventilation delivery device.
  4. Use C-collar for additional stabilization if intubated or when using King Airway.
  5. If Res-Q-POD fills with blood, fluids or emesis - remove and shake fluid(s) out. Re-apply and continue circulation.
  6. Remove Res-Q-POD if patient starts spontaneous respiration(s) or return of spontaneous circulation.

emSop, LLC

9080 - i-gel Airway


Indications :

  • Patient is unconscious and unable to protect own airway.
  • No apparent gag reflex.

Contraindications :

  • Patient with an intact gag reflex.
  • Ingestion of caustic substance(s).

  1. Don protective eyewear, mask and gloves.
  2. Ventilate patient with oral/nasal airways and BVM with 100% supplemental oxygen during preparation of i-gel.
  3. Select appropriate size (Sized by ideal body weight):
    • #1 – for patients 2 kg - 5 kg (4 lbs - 11 lbs)
    • #1.5 – for patients 5 kg - 12 kg (11 lbs - 26 lbs)
    • #2 – for patients 10 kg - 25 kg (22 lbs - 55 lbs)
    • #2.5 - for patients 25 kg - 35 kg (55 lbs - 77 lbs)
    • #3 - for patients 30 kg - 60 kg (60 lbs - 132 lbs)
    • #4 – for patients 50 kg - 90 kg (110 lbs - 198 lbs)
    • #5 – for patients 90+ kg (198+ lbs.)
  4. Open the i-gel package and on flat surface take out the protective cradle containing the device.
  5. Remove the i-gel and transfer to the palm of the same hand that is holding the protective cradle, supporting the device between the thumb and index finger.
  6. Place a small bolus of a water based lubricant, such as K-Y Jelly, onto the middle of the smooth surface of the protective cradle in preparation for lubrication.
  7. Grasp the i-gel with the opposite (free) hand along the integral bite block and lubricate the back, sides and front of the cuff with a thin layer of lubricant.
  8. Grasp the lubricated i-gel firmly along the integral bite block. Position the device so that the i-gel cuff outlet is facing towards the chin of the patient. The patient should be in the "sniffing" postion with head extended and neck flexed unless you suspect c-spine injury, then place in a neutral in-line position. The chin should be gently pressed down before proceeding.
  9. Introduce the leading soft tip into the mouth of the patient in a direction towards the hard palate.
  10. Glide the device downwards and backwards along the hard palate with a continuous but gentle push until a definitive resistance is felt.
  11. The tip of the airway should be located into the upper esophageal opening and the cuff should be located against the laryngeal framework. The incisors should be resting on the integral bite-block.
  12. Attach the manual resuscitator bag to the i-gel Airway device.
  13. Confirm correct placement by listening for breath sounds, observing the chest rise and fall.
  14. Secure the i-gel Airway device with tape or with the supplied head strap. Consider use of C-collar to restrict head movement.
  15. If using i-gel Airway device, consider decompressing the stomach by inserting a nasogastric tube through the gastric outlet on the airway.

  1. Removal of the airway is indicated -
    • IF the patient has a return of gag reflex AND ability to protect own airway,
    • OR

    • If ventilation is inadequate.

  2. Don protective eyewear, mask and gloves.
  3. Vomiting is likely, have suction ready with Yankauer tip.
  4. If not contraindicated by suspected spinal injury, turn the patient to the side.
  5. Carefully remove the i-gel Airway device staying alert for vomiting.
  6. Oxygenate and ventilate as needed.

  1. Sometimes a feel of "give-way" is felt before the end point resistance is met. This is due to the passage of the bowl of the i-gel through the faucial pillars. It is important to continue to insert the device until a definitive resistance is felt. Once definitive resistance is met and the teeth are located on the integral bite-block, do not repeatedly push i-gel down or apply excessive force during insertion.
  2. If there is early resistance during insertion -
    • A "jaw-thrust" (above) or "Insertion with Deep Rotation" (right) is recommended.

  3. It is not necessary to insert fingers or thumbs into the patients mouth during the process of inserting the device.
  4. No more than three attempts in one patient should be attempted.

i-gel Airway Chart

from "IS6.3_igel_UK_issue_11_web.pdf"

emSop, LLC

9090 - EZ-IO


Indications :

  1. SIZE :
    • EZIO - AD for patients known or appearing to be 40kg or greater.
    • OR

    • EZIO - PD for patients 3kg to 39 kg.

  2. Need for vascular access for volume replacement or medication administration in patients with poor venous access or 2 failed IV attempts.
  3. Decreased level of consciousness (GCS of 8 or below.)

Contraindications :

  1. Patients known or appearing less than 3 kg.
  2. Fracture(s) to long bones -
    • Leg Site(s) - Femur or tiba
    • Arm Site(s) - Humerus

  3. Knee replacement (look for large anterior scar.)
  4. Severe osteoporosis or tumor of leg / arm.
  5. Infection at insertion site.
  6. Inability to locate landmarks or excessive tissue at insertion site.

Considerations :

  1. Use outside the above indications/contraindications may be authorized by online medical control.

  1. EZ-IO driver.
  2. EZ-IO needle set.
  3. Arm Band.
  4. Site prep.
  5. Extension set.
  6. 10 ml syringe.
  7. 1 liter bag of normal saline.
  8. External pressure device (or BP cuff.)
  9. Tape/gauze.
  10. 2% Lidocaine (preservative free.)

  1. Prepare the equipment, purge the tubing.
  2. Prep the insertion site as per standard IV access technique.
    1. Locate the patella, tibial tuberosity and flat surface of the tibia.
    2. Insertion site is 1 finger width medial to the tuberosity.
    3. Humeral head may be used as alternate site for patients with "leg" contraindications (above.)

  3. Open the EZ-IO cartridge and attach needle set (confirm "snap".)
  4. Remove needle cap with clockwise rotation.
  5. Insert IO needle -
    1. Stabliize extremity with one hand and position the driver over the site at a 90o angle to flat surface of the bone.
    2. Power the needle through the skin ONLY TO BONE SURFACE
    3. Ensure the 5 mm mark (closest to the flange) on the catheter is visable.
      1. If the mark is not visable, do not proceed, the needle set is not long enough.

    4. Apply firm, steady pressure and power the needle into the bone until the flange touches the skin OR a sudden lack of resistance is flet.
    5. While supporting the needle set with one hand, pull straight back on the driver to detach from needle set.
    6. Grasp the hub firmly with one hand and rotate the stylet counter clockwise until loose, pull it from the hub and place in the styet cartridge.
      1. Place the cartridge in biohazard container.

    7. Confirm placement by :
      1. Visable blood at tip of stylet,
      2. Aspiration of marrow,
      3. Free flow of fluid without evidence of leakage or extravasation.

  6. Flush with 10ml of normal saline.
  7. Secure catheter with tape/gauze.
  8. Attach to 1 liter normal saline bag with external pressure device inflated to 300 mmHg.
  9. Apply EZ-IO arm band.
  10. Monitor for soft tissue swelling/leaks.

  1. If drip rate is slow, flush with 10ml normal saline (5ml for EZIO-PD.)
  2. Any medication that is administered by IV can also be administered by IO.
  3. The device may be left in place for up to 24 hours.
  4. Removal is accomplished by pulling while rotating the center hub counter clockwise.

  1. Insertion of the EZIO-AD & EZIO-PD in conscious patients has been noted to cause mild to moderate discomfort (usually no more painful than a large bore IV.) However, IO infusion for conscious patients has been noted to cause severe discomfort -
    1. Prior to IO syringe bolus (flush) or continuous infusion in alert patients, SLOWLY administer Lidocaine 2% (Preservative Free) through the EZ-IO hub.
      1. EZIO-AD : Slowly administer 20 mg to 40 mg Lidocaine 2% (Preservative Free.)
      2. EZIO-PD : Slowly administer 0.5 mg/kg Lidocaine 2% (Preservative Free.)

emSop, LLC

9100 - PAIN SCALES


DNR Flow Chart

Wong-Baker Faces

DNR Flow Chart

Visual Analog Scale

DNR Flow Chart

FLACC Scale

emSop, LLC

9110 - DO NOT RESUSCITATE (DNR) GUIDELINES


DNR Flow Chart

DO NOT RESUSCITATE (DNR) Flow Chart

emSop, LLC

9120 - EMSRB DNR FORM


emSop, LLC

9130 - MINNESOTA POLST FORM


emSop, LLC

9140 - HENNEPIN COUNTY PANFLU


    These standing orders will be used to provide the best pre-hospital care to the greatest number of people during an extreme situation. They will only be put into place when resources are defined by the system as “Level Red,” which means EMS services are pending or not answering calls for which there is a significant risk of death for the patient. They do not supersede other protocols. You will be notified when this status is in effect.

    Our ethical commitments are:

    1. Limitation of Individual Autonomy: The fair and just rationing of scarce resources requires public health decisions based on objective factors, rather than on the choice of individual leaders, providers, or patients. All individuals should receive the highest level of care given the resources available at the time.
    2. Transparency: Governments and institutions have an ethical obligation to plan allocation through a process that is transparent, open, and publicly debated. Governmental honesty about the need to ration medical care justifies institutional and professional actions of withholding and withdrawing support from individual patients. These restrictive policies must be understood and supported by medical providers and the public, ideally with reassurances that institutions and providers will be acting in good faith and legally protected in their efforts.
    3. Justice/Fairness: The proposed triage process relies on the principle of maximization of benefit to the population served. The triage process treats patients equally based on objective, physiologic criteria, and when these criteria do not clearly favor a particular patient, “first come, first serve” rules will apply.
    4. Assurance: In order to ensure “procedural justice,” EMS triage processes will be regularly evaluated to assure that the process has been followed fairly and consistently.
    5. Documentation: MNTrac records will include policy notations including the times the “Level Red” was in effect.

    When an ambulance arrives on scene during “Level Red” status, instead of automatically offering transport to an emergency department, as under normal practice, you will assess the patient’s objective condition and triage him/her into the following categories:

    Provide homecare information.
    Refer to a clinic or other medical destination.
    Refer to use of alternate transportation to a hospital, clinic or other medical destination.
    Transport by (and at the descretion of) law enforcement.
    Transport by ambulance to a hospital or other medical destination.

    Standing Orders:

    1. If the patient’s complaint or symptoms are not listed in this Appendix, Paramedic’s discretion is advised as long as the decision is not in conflict with SOP.
    2. When resources during a Pandemic are “Level Red,” automatically offer to transport patients with the following presentations:
    3. 1. Paramedic discretion - suspicion of critical injury/illness.
      2. Altered vital signs (or age-specific abnormal vital signs,) including any one of these:

      • SBP < 90.
      • SpO2 < 92%.
      • RR > 30 (or respiratory distress.)
      • HR > 120, or delayed capillary refill.

      3. Breathinhg:

      • Respiratory distress.
      • Cyanosis or pallor/ashen skin.

      4. Circulation/Shock:

      • Signs or symptoms of shock.
      • Severe/uncontrollable bleeding.
      • Large amounts of blood (or suspected blood) in emesis or stool.

      5. Neurologic:

      • Unconscious or altered level of consciousness.
      • New focal neurologic signs (CVA, etc.)
      • Status, multiple or new-onset seizure.
      • Severe headaches - especially sudden onset or accompanied with neck pain/stiffness.
      • Head injuries with more than brief loss of consciousness or continued neck pain, dizziness, vision disturbances, ongoing amnesia or headache, and/or nausea and vomiting.

      6. Trauma:

      • Significant trauma with chest/spinal/abdominal/neurologic injury deemed unstable or potentially unstable.
      • Suspected fractures or dislocations that cannot be safely transported by private vehicle.

      When resources during a Pandemic are “Level Red,” consider patients with the following presentations for:

      • transportation by ambulance - Note that many "transport by ambulance" patients will not require emergency transport to the hospital – in which case, the crew may answer additional calls until the ambulance is full, or a critical patient is picked up, depending on system call volumes.
      • transportation by alternate means - private vehicle or police to clinic or hospital. Except in very limited cases, the patient should NOT self - transport to the hospital/clinic, but could be driven by someone else.
      • homecare - Give patient the homecare form for their complaint and advise to contact personal medical provider if symptoms persist or worsen. The form will have information pertaining to their complaint and list ways of caring for themselves, as well as what to look for that would prompt self-transport to a clinic or hospital, or transport via ambulance to the hospital. Advise the patient that this does not restrict them from seeking care at a clinic or hospital on their own, should they desire.

      1. ABDOMINAL PAIN:
        • Pulsating mass.
        • Marked tenderness/guarding.
        • Pain radiating into back and/or groin/inner thighs.
        • Recurrent severe vomiting not associated with diarrhea.
        to
        • Recurrent severe vomiting associated with diarrhea - to emergency if associated with signs/symptoms of dehydration, to urgent care or clinic if no dizziness nor vital sign changes and normal exam.
        • Intermittent vomiting and diarrhea without blood or evidence of dehydration.

      2. ANAPHYLAXIS/STINGS:
        • Patients who have had epinephrine administered for symptoms.
        • Patients experiencing airway, hypotension or respiratory symptoms, after an allergy exposure.
        to OR
        • Patients with itching after exposure - if rapid onset of symptoms, may require EMS transport; if delayed > 1 hour, safe for private transport. All patients with history of anaphylaxis should be seen in emergency room if possible. Others may be seen in clinic or urgent care. EMS may administer diphenhydramine prior to clearing scene, up to 1mg/kg.

      3. BACK PAIN:
        • Acute trauma with midline bony spinal tenderness.
        • New onset of extremity weakness, sensory deficits, other neurological changes, incontinence of urine or bowel, urinary retention or bloody urine.
        • Concern for abdominal aortic aneurysm.
        • Pain radiating into abdomen or groin/inner thighs.
        OR
        • Inability to ambulate/care for self.
        • Concern for kidney stone, bloddy urine.

      4. BEHAVIORAL:
        • Uncontrolled agitation requiring sedation by EMS.
        OR OR
        • Suicidal ideation - must be left with a responsible party.
        OR
        • Other emotionally disturbed patients may be transported at law enforcement's discretion or by other means.

      5. BLEEDING (LACERATIONS, ABRASIONS OR AVULSIONS):
        • Patient is on blood thinner(s) with significant ongoing bleeding or large hematoma.
        to
        • Significant lacerations after bandaging - heavily contaminated, bite-related, likely to involve foreign body, deep structure injury, sensory/motor deficit - to emergency room.
        • Lacerations requiring simple repair - consider self- transport to physician's office or urgent care center (however, some offices do not do procedures; patient will need to call ahead.)
        • Abraisions or avulsions not requireing suturing or repair, no significant contamination
        • Minor lacerations that do not require sutures.

      6. BURNS:
        • All chemical or electrical burns.
        • Suspected inhalant burn.
        • Significant third degree burns.
        • Second degree burns to 5% or less BSA.
        • Second degree burns to face, mouth.
        • Severe pain.
        • Second degree burns to hands or feet, or 1% to 5% BSA to other location(s) - (size of patient's palmer surface.)
        • Second degree burns less than 1% BSA, non-critical location.
        • First degree burns.

      7. CARDIAC ARREST:
        • Witnessed down time of 10 minutes or less - follow usual resuscitation protocol.
        • All others - report death to dispatch and return to service; do not wait for law enforcement or medical examiner arrival.

      8. CHEST PAIN:
        • Chest pain or other signs or symptoms suspicious for cardiac ischemia, pulmonary embolus, or other life threat.
        to OR
        • Chest pain ongoing for over 12 hours and a normal ECG.
        • Pleuritic chest pain without hypoxia.
        • Chest pain reproducible on physical exam to palpation is generally NOT concerning; unless ECG changes or known cardiac disease, unlikely to require treatment for acute coronary syndrome.

      9. DIABETIC:
      10. OR
        • Any patient on oral diabetes medications with low blood glucose - if transported by private vehicle must NOT drive self.
        • Critical high glucose or signs of Diabetic Ketoacidosis/dehydration.
        • Patients with typical hypoglycemia and explanation for low sugar (did not eat, etc.) can be left without medical control contact as long as family/friend is present and patient is eating.

      11. ENVIRONMENTAL:
        • Heat-related illness with any alteration in mental status (confusion, decreased LOC.)
        • Frozen extremity.
        • Hypothermia with AMS.
        OR
        • Frostbite to face, hands, feet, other locations suspected deeper inury, blisters, or frozen to touch.
        • Heat-related illness without alteration in mental status - initiate external cooling at home under supervision of friends/family.
        • Minor frostbite with tissues now soft, pink, no blisters and NOT involving digits.

      12. ETOH/SUBSTANCE ABUSE:
        • Very decreased LOC or other confounding issues (head injury, suspicion of aspiration.)
        • Otherwise may be transported at law enforcement's discretion.
        • Patient may be left with a responsible individual who can assist the patient.
        • Able to ambulate safely without assistance.

      13. EYE PAIN:
        • Impaled objects or possible penetrating injury to eye, or globe rupture.
        • Chemical esposures (alkaline) - after decontamination and initial rinsing.
        OR to
        • Eye pain and/or acute changes to vision should receive transport for urgent evaluation to emergency department or other qualified clinic (e.g. eye clinic.)
        • Chemical exposures (non-alkaline) - consult poison control for instructions; transport if symptoms/dangerous exposure.
        • Chemical exposures (non-alkaline) - consult poison control for instructions; if no symptoms and limited toxicity likely, give instruction sheet.

      14. FEVER:
        • Fever plus altered mental status including confusion.
        • Fever plus severe symptoms by paramedic assessment.
        • Fever plau seizures, lethargy, stiff neck, rash or blistering.
        OR to
        • Fever estimated to be at or above 100.5o for three months or less - to emergency room or clinic urgently.
        • History of fever greater then 3 months that does not reduce with anti-pyretics, or fever lasting more then 5 days - emergency room, urgent care, or clinic.

      15. HEADACHE:
        • With vision deficit, lethargy or other qualifies such as fever, etc.
        • New headaches for patient require assessment
        • Usual headaches for patient may require treatment.

      16. MUSCULOSKELETAL INJURIES (ISOLATED):
        • Loss of distal pulses.
        • Unable to effectively splint the affected body part.
        • Neurological changes or deficits.
        • Open fractures.
        • Displaced fractures or pain requiring injectable narcotics.
        • Suspected fractures that are stable and do not require injected analgesia may be splinted appropriately and transported by private vehicle.
        or
        • Neck pain and back pain after MVC that is delayed in onset and not associated with midline tenderness or neurologic systems.

      17. NOSE BLEED:
        • Signs of hypovolemia or dizziness upon standing.
        • Patient is on blood thinners (Coumadin, lovenox, clopidogrel, etc.)
        • Continued high blood pressure (SBP > 200) in setting of nosebleed.
        • Continued severe bleeding despite EMS efforts to control.
        • All others.

      18. OB/PREGNANCY:
        • Imminent delivery.
        • Pain in abdomen or back.
        • Profuse vaginal bleeding.
        • Third trimester (> 24 weeks) bleeding.
        • Pre/Eclampsia - syncope, seizure, altered mental status, SBP equal to or greater then 140.
        • All others.

      19. SWALLOWING PROBLEM:
        • Patient unable to manage own secretions due to pain or obstruction.
        • All others.

      20. SYNCOPE:
        • History of coronary disease or heart failure.
        • Age of 55 or over.
        • Pregnant.
        • Chest pain, headache or shortness of breath (or other symptoms concerning to paramedics.)
        to OR
        • Likely dehydration with dizziness preceding the snycope.
        • Other underlying medical conditions.

      21. TOXICOLOGICAL:
      22. or to OR
        • Overdose or other toxic exposure - contact Poison Control and/or online medical control.
        • If intentional - see section 4:Behavioral in this appendix.

      23. VULNERABLE PERSON IN POTENTIAL DANGER:
        • EMS should assure that person will not be left in dangerous environment.
        • If safe disposition and transport can be arranged and the injuries do not otherwise require medical evaluation, other transport may be appropriate.

emSop, LLC

9150 - PEDIATRIC REFERENCE CHART


emSop, LLC

9900 - ADENOSINE, IV



    Generic Name adenosine IV
    Trade Name Adenocard IV
    Classification Antiarrhythmics
    Indications To convert acute PSVT to normal sinus rhythm. Includes PSVT associated with accessory bypass tracts (Wolff-Parkinson-White syndrome.)
    Contraindications Patients with hypersensitivity to the drug. Those in second or third degree heart block, sick sinus syndrome, or symptomatic bradycardia.
    Adverse Effects Chest pain, dizziness, dyspnea and/or shortness of breath, facial flushing, headache, lightheadedness, blurred vision, nausea, metallic taste, and numbness. More serious symptoms are persistent arrythmias, and bronchospasm.
    Precautions Could produce bronchoconstriction in patients with asthma. Patients who develop high level heart block after a single dose should not receive additional doses. Use with caution in patients receiving digoxin and verapamil in combination. Theraputic levels of theophylline and methylxanthines affect the response of adenosine. Dipyridamole potentiates its effect.
    Concentration(s) 3 mg per 1 mL

emSop, LLC

9905 - ALBUTEROL SULFATE INHALATION SOLUTION, 0.083%



    Generic Name albuterol sulfate Inhalation Solution, 0.083%
    Trade Name Ventolin
    Classification Bronchodilators
    Indications Indicated for the relief of bronchospasm in patients two years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm.
    Contraindications Hypersensitivity to the drug.
    Adverse Effects Tachycardia, hypertension, bronchospasm, bronchitis, nasal congestion, tremors, dizziness, nervousness, headache, and sleeplessness.
    Precautions Used with caution in patients with cardiovascular disorders, especially coronary insufficiency, cardiac arrhythmias and hypertension. MAO inhibitors, tricyclic antidepressants, may potentiate action on CV system. Propranolol and other beta blockers inhibit the effect of albuterol.
    Concentration(s) 2.5 mg in 3 mL

emSop, LLC

9910 - TETRACAINE HYDROCHLORIDE 0.5% OPHTHALMIC SOLUTION



    Generic Name tetracaine hydrochloride
    Trade Name Altacaine, Tetcaine, TetraVisc, TetraVisc Forte
    Classification Topical anesthetic agent
    Indications Ophthalmic procedures in which it can provide good local anesthesia (flushing eyes out after chemical injury.)
    Contraindications Hypersensitivity to the drug.
    Adverse Effects Hypersensitivity reactions, conjunctival redness, transient eye pain, and lacrimation or increased winking. A hyperallergic corneal reaction may occur which includes an acute diffuse epithelial keratitis.
    Precautions Should be used cautiously in patients with cardiac disease, or hyperthyroidism. Prolonged use may produce permanent corneal opacification with loss of vision.
    Concentration(s) 0.5% in 4 mL ampule

emSop, LLC

9915 - AMIODARONE HYDROCHLORIDE (CORDARONE)



    Generic Name amiodarone hydrochloride
    Trade Name Cordarone
    Classification Antiarrhythmics
    Indications Used in a wide variety of atrial and ventricular tachyarrhythmias and for rate control of rapid atrial arrhythmias in patients with impaired LV function when digoxin has proven ineffective.
    Contraindications Marked sinus bradycardia due to severe sinus node dysfunction, second-or third-degree AV block, syncope caused by bradycardia (except when used with a pacemaker). Cardiogenic shock. Lactation.
    Adverse Effects Cough and progressive dyspnea. Worsening of arrhythmias, symptomatic bradycardia, sinus arrest, SA node dysfunction, CHF edema, hypotension, cardiac conduction abnormalities, cardiac arrest, abnormal involuntary movements, headache, nausea and vomitting, abdominal pain, flushing, and shock
    Precautions May produce vasodilation and hypotension. May have negative inotropic effects. May prolong QT interval. Do not routinely use with other drugs that prolong QT interval. Use with caution if renal failure is present.
    Concentration(s) 50 mg per 1 mL

emSop, LLC

9920 - ASPIRIN (ASA)



    Generic Name acetylsalicylic acid
    Trade Name Aspirin ASA, Ecotrin
    Classification Antiplatelet effect, nonnarcotic analgesic, antipyretic.
    Indications Suspicion of cardiac ischemia.
    Contraindications Hypersensitivity to drug. Patients with active ulcer disease. Pediatric patients.
    Adverse Effects Bleeding gums, signs of GI bleeding, and petechiae. Aspirin will increase bleeding time.
    Precautions Use with caution in patients with GI lesions, impaired renal function, hypoprothrombinemia, vitamin K deficiency, thrombocytopenia, or severe hepatic impairment.
    Concentration(s) 81 mg per tablet

emSop, LLC

9925 - ATROPINE SULFATE IV



    Generic Name atropine sulfate IV
    Trade Name Atropine IV
    Classification Antiarrhythmic, anticholinergic, antidote.
    Indications Treatment of symptomatic sinus bradycardia or atrioventricular block at the nodal level. Usually not effective when infranodal block suspected. Second drug for asystole or PEA.
    Contraindications Hypersensitivity to the drug, unstable cardiovascular status, myocardial ischemia, glaucoma, and obstructive disease of the GI or GU tracts.
    Adverse Effects Postural hypotension, blurred vision, dryness of the mouth, GI reflux, nausea, vomiting, paralytic ileus, tachyarrhythmias, and urinary retention.
    Precautions Use with caution in presence of myocardial ischemia and hypoxia. Avoid in hypothermic bradycardia. Usually not effective in second degree block type II and third degree blocks with wide QRS complexes. Antacids decrease absorption of med.
    Concentration(s) 0.1 mg per 1 mL

emSop, LLC

9930 - IPRATROPIUM INHALATION (ATROVENT)



    Generic Name ipratropium bromide
    Trade Name Atroven
    Classification Bronchodilators
    Indications Either alone or with other bronchodilators, especially beta andrenergics is used for treatment of bronchospasm associated with chronic obstructive pulmonary disease, including asthma chronic bronchitis and emphysema.
    Contraindications Hypersensitivity to the drug, Atropine and its derivatives, and those with a history of hypersensitivity to soy lecithin or related food products such as soybeans and peanuts.
    Adverse Effects Dizziness, headache, nervousness, palpitations, hypertension, cough, blurred vision, rhinitis, epistaxis, GI distress, chest pain, flu-like symptoms.
    Precautions Use cautiously in patients with angle-closure glaucoma, prostatic hyperplasia, and bladder-neck obstruction. Avoid leakage around the face mask, temporary blurring of vision or eye pain may occur.
    Concentration(s) 0.5 mg in 2.5 mL

emSop, LLC

9935 - DIPHENHYDRAMINE HCL (BENADRYL) IV



    Generic Name diphenhydramine hydrochloride
    Trade Name Benadryl IV
    Classification Antihistamine, antidyskinetic, antiemetic, antivertigo agent, sedative-hypnotic.
    Indications Supplemental therapy to epinephrine in anaphylaxis and other uncomplicated allergic reactions requiring prompt treatment.
    Contraindications Hypersensitivity to the drug, during acute asthmatic attacks, in newborns, and premature neonates.
    Adverse Effects Palpitations, hypotension, tachycardia, confusion, insomnia, headache, vertigo, restlessness, tremor, seizures, blurred vision, nausea and vomiting, and anaphylactic shock.
    Precautions Use with extreme caution in patients with prostatic hyperplasia, asthma or COPD, increased intraocular pressure, hyperthyroidism, CV disease, or hypertension. Avoid SC or perivascular injection. Potential CNS depression when used in the presence of sedating medications, alcohol, or other illicit substances.
    Concentration(s) 50 mg per 1 mL

emSop, LLC

9940 - CALCIUM CHLORIDE 10%



    Generic Name calcium chloride 10%
    Trade Name Calcijex
    Classification Antihyperkalemic, antihypermagnesemic, cardiotonic, antihypocalcemic.
    Indications Known or suspected hyperkalemia (e.g., renal failure), Hypocalcemia (e.g., after multiple blood transfusion, and as an antidote for toxic effects (hypotension and arrhythmias) from calcium channel blocker overdose or B-Adrenergic blocker overdose.
    Contraindications Hypersensitivity to the drug, digitalized patients, hypercalcemia, ventricular fibrillation.
    Adverse Effects May cause bradycardia, cardiac arrest, metallic, calcium or chalky taste, prolonged state of cardiac contraction, sense of oppression, or tingling sensation, especially with a too-rapid rate of administration. (Overdose) nausea and vomiting, coma, and sudden death.
    Precautions Do not use routinely in cardiac arrest; do not mix with Sodium Bicarbonate. Three times more potent then calcium gluconate. For IV use only.
    Concentration(s) 100 mg per 1 mL

emSop, LLC

<

9945 - DEXTROSE IV



    Generic Name D-glucose or glucose
    Trade Name Dextrose IV
    Classification Nutritional (carbohydrate).
    Indications Diabetics who are unable to take oral fluids due to altered level of consciousness and low blood glucose.
    Contraindications Delirium tremens with hydration, diabetic coma while blood sugar is excessive, hepatic coma intracranial or intraspinal hemorrhage, glucose-galactose malabsorption syndrome.
    Adverse Effects Pulmonary edema, exacerbated hypertension, heart failure, (fluid overload-congested states), hyperglycemia, (during infusion), hyperosmolar syndrome (mental confusion, loss of consciousness), hypokalemia, reactive hypoglycemia (after infusion)
    Precautions Use with caution in patients with cardiac or pulmonary disease, hypertension, renal insufficiency, urinary obstruction, or hypovolemia. Avoid extravasation which may cause tissue sloughing, necrosis, and phlebitis.
    Concentration(s) 500 mg per 1 mL (0.5 GRAMS per 1 mL)

emSop, LLC

9950 - EPINEPHRINE



    Generic Name epinephrine hydrochloride
    Trade Name Adrenalin
    Classification Cardiac stimulant, bronchodilator, antiallergic, and vasopressoR.
    Indications Cardiac arrest: VF, pulseless VT, asystole, pulseless electrical activity. Anaphylaxis, severe allergic reactions, and profound bradycardia or hypotension.
    Contraindications Patients with angle-closure glaucoma, shock (other than anaphylactic shock), organic brain damage, cardiac dilation, coronary insufficiency, cerebral arteriosclerosis or labor and delivery. Do not use to treat overdose of adrenergic blocking agents.
    Adverse Effects Nervousness, tremor, headache, agitation, dizziness, weakness, cerebral hemorrhage, palpitations, hypertension, tachycardia, anginal pain, nausea and vomiting, and dyspnea.
    Precautions High doses do not improve survival or neurologic outcome and may contribute to postresuscitation myocardial dysfunction. Raising blood pressure and increasing heart rate may cause myocardial ischemia, angina and increased myocardial oxygen demand. Higher doses maybe required to treat poison/drug-induced shock. Do not use concurrently with Brevibloc. The effects of the drug maybe potentiated by tricyclic antidepressants.
    Concentration(s) 1 mg per 1 mL for 1:1000 (30 mL vial)||||| - ||||| 0.1 mg per 1 mL for 1:10,000 (pre-filled syringe)

emSop, LLC

9955 - FENTANYL



    Generic Name fentanyl
    Trade Name Duragesic, Subsys, Abstral
    Classification Opioid Analgesic
    Indications Control of pain associated with musculoskeletal pain.
    Contraindications Hypersensitivity to fentanyl or other fentanyl analogues. May cause muscle rigidity (including muscles of respiration) if given in high dose or too rapidly.
    Adverse Effects CNS: CNS depression; CV: hypotension, bradycardia; GI/GU: vomiting, nausea, diarrhea; Resp: Respiratory depression, apnea, depressed C02 sensitivity.
    Precautions May cause muscle rigidity (including muscles of respiration) if given in high dose or too rapidly.
    Concentration(s) 50 mcg per 1 mL

emSop, LLC

9960 - GLUCAGON



    Generic Name glucagon
    Trade Name GlucaGen
    Classification Antihypoglycemic, antidote, and diagnostic agent.
    Indications Treatment of severe hypoglycemia, helpful in reversing adverse beta-blockade of beta-adrenergic blocking agents and calcium channel blockers, diagnostic aid in radiologic exam of abdomen.
    Contraindications Known hypersensitivity to drug, and in patients with pheochromocytoma or with insulinoma (tumor of pancreas).
    Adverse Effects Hyperglycemia (excessive dosage), nausea and vomiting hypersensitivity reactions (anaphylaxis, dyspnea, hypotension, rash), increased blood pressure, and pulse; this maybe greater in patients taking beta-blockers.
    Precautions Give with caution to patients that have low levels of releasable glucose (e.g., adrenal insufficiency, chronic hypoglycemia, and prolonged fasting). Potentiates oral anticoagulants. Depletes glycogen stores especially in children and adolescents.
    Concentration(s) 1 mg per 1 mL

emSop, LLC

9965 - HALOPERIDOL (HALDOL)



    Generic Name haloperidol
    Trade Name Haldol
    Classification Antipsychotic
    Indications Psychotic disorders including manic states, drug-induced psychoses, and schizophrenia. Severe behavior problems in children (those with combative, explosive hyperexcitability not accounted for by immediate provocation). Short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct consisting of impulsivity, poor attention, aggression, mood lability, or poor frustration tolerance. Control of tics and vocal utterances associated with Gilles de la Tourette's syndrome in adults and children. The decanoate is used for prolonged therapy in chronic schizophrenia. Investigational: Antiemetic for cancer chemotherapy, phencyclidine (PCP) psychosis, intractable hiccoughs, infantile autism. IV for acute psychiatric conditions.
    Contraindications Use with extreme caution, or not at all, in clients with parkinsonism. Lactation.
    Adverse Effects CNS: Sedation, drowsiness, lethargy, headache, insomnia, confusion, vertigo, seizures, neuroleptic malignant syndrome. Extrapyramidal symptoms, especially akathisia and dystonias, occur more frequently than with the phenothiazines. EENT: Blurred vision. GI: Dry mouth, anorexia, constipation, diarrhea, nausea, vomiting, dyspepsia. Other: Urine retention, menstrual irregularities, priapism, leukocytosis, altered liver function test results, rash, diaphoresis.
    Precautions IM dosage is not recommended in children. Geriatric clients are more likely to exhibit orthostatic hypotension, anticholinergic effects, sedation, and extrapyramidal side effects (such as parkinsonism and tardive dyskinesia).
    Concentration(s) 5 mg per 1 mL

emSop, LLC

9970 - KETAMINE HYDROCHLORIDE (KETALAR)



    Generic Name ketamine hydrochloride
    Trade Name Ketalar
    Classification Non-barbiturate anesthetic.
    Indications Severely agitated patient that poses an immediate threat to himself/herself or others and usual chemical or physical restraints may not be appropriate or safely used.
    Contraindications Ketamine is contraindicated in patients with any condition in which a significant elevation of blood pressure would be hazardous such as: severe cardiovascular disease, heart failure, severe or poorly controlled hypertension, recent myocardial infarction, history of stroke, cerebral trauma, intracerebral mass or hemorrhage. Also contraindicated for hypersensivity to the drug.
    Adverse Effects Psychological manifestations varying in severity between pleasant dream-like states, vivid imagery, hallucinations, nightmares or illusions and delirium. Other adverse effects include: Diplopia, nystagmus, blood pressure and pulse rate elevations, and local pain and exanthema at the injection site
    Precautions Barbiturates and Ketamine, being chemically incompatible because of precipitate formation, should not be injected from the same syringe. Use with caution in the chronic alcoholic and the acutely alcohol-intoxicated patient. The intravenous dose should be administered over a period of 60 seconds. More rapid administration may result in respiratory depression or apnea and enhanced pressor response. Resuscitative equipment should be ready for use.
    Concentration(s) 100 mg per 1 mL

emSop, LLC

9975 - LIDOCAINE HYDROCHLORIDE, IV



    Generic Name lidocaine hydrochloride IV
    Trade Name Xylocaine IV
    Classification Antiarrhythmic
    Indications Cardiac arrest from VF/VT (class II B) Stable VT, wide-complex tachycardias of uncertain type, wide-complex PSVT (class IIB).
    Contraindications Hypersensivity to the drug. Stokes-Adams syndrome, Wolff-Parkinson-White syndrome, severe degrees of SA, AV, or intraventricular block (when no pacemaker is present.)
    Adverse Effects Anaphylaxis, bradycardia, hypotension, cardiovascular collapse, seizures, malignant hyperthermia, respiratory depression, tremors, lightheadedness, confusion, tinnitus, blurred or double vision, and vomiting
    Precautions Prophylactic use in AMI patients is not recommended. Discontinue infusion immediately if signs of toxicity develop. Elderly clients who have hepatic or renal disease or who weigh less then 45.5 kg should be watched closely for adverse side effects. Do not add lidocaine to blood transfusion assembly. Potentiates amiodarone, beta-adrenergic blockers (Inderal) and Tagamet. Toxicity can occur due to reduced metabolism of lidocaine.
    Concentration(s) 20 mg per 1 mL

emSop, LLC

9980 - MAGNESIUM SULFATE HEPTAHYDRATE



    Generic Name Magnesium Sulfate heptahydrate
    Trade Name Magnesium Sulfate
    Classification Antiarrhythmic, electrolyte replenisher, and anticonvulsant.
    Indications Refractory VF (after lidocaine), torsades de pointes with a pulse, life threatening ventricular arrhythmias due to digitalis toxicity, adjunctive to alleviate bronchospasm in acute asthma, control of seizures in pregnancy, and control of hypertension in acute nephritis in children.
    Contraindications In the presence of heart block or myocardial damage, hypersensitivity to drug, and within 2 hours preceding delivery of PIH patient.
    Adverse Effects CNS depression, hypotension, circulatory collapse, depression of myocardium. Sweating, hypothermia, muscle paralysis, respiratory paralysis, suppression of knee jerk reflex, and changes in ECG, (increased PR interval, increased QRS complex, and prolonged QT interval).
    Precautions Morphine and Valium potentiate respiratory depression when given to patient receiving MgSO4. Calcium gluconate should always be available to treat possible respiratory depression due to MgSO4. Toxic level is >10 mg/dL.
    Concentration(s) 500 mg per 1 mL

emSop, LLC

9985 - MIDAZOLAM HYDROCHLORIDE



    Generic Name midazolam hydrochloride
    Trade Name Versed
    Classification Sedative-hypnotic, benzodiazepine, amnestic, anesthetic adjunct.
    Indications To produce sedation, relieve anxiety, and impair memory of procedural events. Used with or without narcotic for conscious sedation before short procedures. Also as a component in the induction of anesthesia before administration of other anesthetic agents, and for patients in status seizures.
    Contraindications Hypersensitivity to the drug, and acute narrow-angle glaucoma. Not recommended in pregnancy, childbirth, breast-feeding, shock, coma, acute alcohol intoxication with depression of vital signs.
    Adverse Effects Serious cardiorespiratory events (airway obstruction, apnea, hypotension, oxygen desaturation, respiratory and or cardiac arrest), paradoxical behavior or excitement. Other common side effects are coughing, headache, hiccups, nausea and vomiting, and nystagmus (especially in children).
    Precautions Use cautiously in patients with uncompensated acute illness and in elderly or debilitated patients. Administer slowly over at least 2 minutes. Use with caution in neonates. Versed does not protect against the intracranial pressure or against the pulse and blood pressure rise associated with intubation. Erythromycin may alter the metabolism of Versed. Oral contraceptives prolong the half-life. Sedative effects may be antagonized by theophylline.
    Concentration(s) 5 mg per 1 mL

emSop, LLC

9990 - MORPHINE SULFATE, IV



    Generic Name Morphine Sulfate
    Trade Name Morphine Sulfate (names may vary if preservative free)
    Classification Narcotic analgesic, adjunct, pulmonary edema.
    Indications Analgesic of choice in pain associated with myocardial infarction that is unresponsive to nitrates. Treatment of acute pulmonary edema associated with left ventricular failure, if blood pressure is adequate. Used for sedation, to decrease anxiety and facilitate induction of anesthesia.
    Contraindications Hypersensitivity to opiates, acute bronchial asthma, heart failure secondary to lung disease, upper airway obstruction, acute alcoholism, convulsive states, and paralytic ileus.
    Adverse Effects Seizures (with large doses), hypotension, bradycardia, cardiac arrest, or may see tachycardia, and hypertension. Nausea and vomiting, ileus, urine retention, respiratory depression and arrest, hypothermia, and increased intracranial pressure may also been seen.
    Precautions Causes hypotension in volume-depleted patients. Administer slowly and titrate to effect. May cause apnea in asthmatic patients. May also cause increase ventricular response rate in presence of supraventricular tachycardias. Use with caution in the elderly, head injuries with increased intracranial pressure, COPD, severe hepatic or renal disease.
    Concentration(s) 10 mg per 1 mL

emSop, LLC

9995 - NALOXONE HYDROCHLORIDE (NARCAN) IV



    Generic Name naloxone hydrochloride
    Trade Name Narcan
    Classification Narcotic (opioid) antagonist, Antidote.
    Indications Indicated for complete or partial reversal of known or suspected narcotic-induced respiratory depression and overdose. Antidote for natural and synthetic narcotics. Also indicated for the diagnosis of suspected opioid tolerance.
    Contraindications Hypersensitivity to the drug. The naloxone challenge test should not be performed in patients showing S/S of withdrawal or whose urine contains opioids.
    Adverse Effects May see VF, tachycardia, hypertension, nausea, vomiting, and diaphoresis, in higher doses. Tremors and withdrawal symptoms in narcotic-dependent patients.
    Precautions May precipitate acute withdrawal symptoms in narcotic addicts. Effects of drug may not outlast effects of narcotics. Use with caution in patients with cardiac disease or those receiving cardiotoxic drugs. It is ineffective against respiratory depression caused by barbiturates, anesthetics, other nonnarcotic agents, or pathologic conditions.
    Concentration(s) 0.4 mg per 1 mL

emSop, LLC

10000 - NITROGLYCERINE, METERED DOSE SPRAY



    Generic Name nitroglycerin lingual spray
    Trade Name Nitroglycerin spray
    Classification Antianginal, coronary vasodilator, antihypertensive.
    Indications Initial antianginal for suspected ischemic pain. Drug of choice in unstable anginaor CHF associated with acute myocardial infarction, and suspected pulmonary edema when systolic blood pressure is greater than 140.
    Contraindications Hypersensitivity to nitrates, head trauma with increased intracranial pressure, hypotensive patients, severe bradycardia or tachycardia, RV infarction, Viagra within 24 hours, and severe anemia.
    Adverse Effects Headache, transient episodes of light-headedness related to blood pressure changes, hypotension, syncope, crescendo angina, rebound hypertension, and anaphylactoid reactions. Abdominal pain and vomiting may also be seen.
    Precautions Do not shake aerosol spray container because this affects metered dose. Patient should sit or lie down when taking this drug. Concomitant use of nitrates and alcohol may cause hypotension. Marked symptomatic orthostatic hypotension may occur when calcium channel blockers and oral controlled-release nitroglycerin are used in combination.
    Concentration(s) 0.4 mg per spray

emSop, LLC

10005 - ORAL GLUCOSE



    Generic Name oral glucose
    Trade Name Glutose, Glucose Gel, Insta-Glucose, GlucoBurst
    Classification Antihypoglycemic
    Indications Hypoglycemia in a known diabetic with confusion or an altered level of consciousness.
    Contraindications Unconscious, unable to swallow, hypersensitivity to drug.
    Adverse Effects If ingested may cause irritation of the gastrointestinal tract, nausea, vomiting, and/or allergic reaction.
    Precautions Reassess mental status to determine if drug has had an effect.
    How Supplied Viscous gel or paste in a tube.
    Dosage 80 Gm per tube

emSop, LLC

10010 - SODIUM BICARBONATE



    Generic Name Sodium Bicarbonate
    Trade Name Sodium Bicarbonate
    Classification Electrolyte replenisher, alkalizing agent.
    Indications Metabolic acidosis caused by circulatory insufficiency resulting from shock or severe dehydration, severe renal disease, cardiac arrest, primary lactic acidosis, tricyclic overdoses, and hyperkalemia.
    Contraindications Patients with metabolic or respiratory alkalosis, patients losing chlorides by vomiting or GI suction, patients receiving diuretics known to produce hypochloremic alkalosis, and patients with hypocalcemia in which alkalosis may produce tetany, hypertension, seizures, or heart failure.
    Adverse Effects Gastric distention, belching, flatulence, hypokalemia, metabolic alkalosis, hypernatremia, hyperosmolarity, hyperirritability or tetany. Extravasation of IV Sodium Bicarbonate may cause chemical cellulitis with tissue necrosis.
    Precautions Not recommended for routine use in cardiac arrest patients. Sodium Bicarbonate inactivates norepinephrine, and dopamine, and forms a precipitate with calcium. Use with caution in the elderly with renal or cardiovascular insufficiency with or without CHF.
    Concentration(s) 1 mEq per 1 mL

emSop, LLC

10015 - TERBUTALINE SULFATE



    Generic Name terbutaline sulfate
    Trade Name Brethine, Bricanyl
    Classification Sympathomimetic, (bronchodilator), Uterine relaxant.
    Indications Used for prevention and reversal of bronchospasm in patients with bronchial asthma and reversible bronchospasm associated with bronchitis and emphysema.
    Contraindications Patients with hypersensitivity to drug or sympathomimetic amines, cardiac arrhythmias with tachycardia or digitalis toxicity, uncontrolled hypertension, and any preexisting maternal medical conditions adversely affected by beta-mimetic drugs.
    Adverse Effects Paradoxical bronchospasm with prolonged usage, nervousness, tremor, drowsiness, headache, weakness, palpitations, tachycardia, heartburn, nausea, vomiting, and hypokalemia (with high doses).
    Precautions Use cautiously in patients with CV disorders, hyperthyroidism, diabetes, or seizure disorders. Drug is not recommended for children under 12 years of age because of insufficient clinical data. Protect ampule from light. Do not use if discolored. Significant changes in systolic and diastolic blood pressure may occur in some patients.
    Concentration(s) 1 mg per 1 mL

emSop, LLC

10020 - TRANEXAMIC ACID (TXA)



    1. Background
      1. Plasmin breaks down clots by degrading fibrin (fibrinolysis). Tranexamic Acid (TXA) is an amino acid that blocks plasminogen from being converted to plasmin, thus tipping the balance from fibrinolysis toward clot formation.

    2. Indications
      1. Patients age (known or appearing) ≥ 16 (able to drive)
      2. Blunt trauma or non-compressible hemorrhage with signs and symptoms of hemorrhagic shock (BP < 90 and/or HR > 120)
      3. Estimated transport time to hospital > 20 min
      4. Time since injury < 3 hrs.

    3. Contraindications
      1. Hypersensitivity
      2. Time since injury > 3 hrs.
      3. Age < 16
      4. Thromboembolic event (CVA, MI, PE) in past 24 hrs
      5. Hypotension secondary to suspected spinal cord injury/shock.
      6. Traumatic arrest with > 5 min of CPR and no ROSC.

    4. Protocol
      1. Provide necessary trauma care including hemorrhage control
        1. Administering TXA should not delay or inhibit providing necessary trauma care
      2. Infuse over 10 min (~ 4 drips/second)
      3. Communicate TXA administration to receiving facility.

emSop, LLC

10025 - ONDANSETRON (ZOFRAN)



    Generic Name ondansetron
    Trade Name Zofran
    Classification Antiemetic
    Indications Severe Nausea and vomiting.
    Contraindications Hypersensitivity to any component of the preparation.
    Adverse Effects The most common reported adverse affects are headache, diarrhea, blurred vision, constipation, fever and fatigue.
    Precautions Very rarely and predominantly with intravenous ondansetron, transient ECG changes including QT interval prolongation have been reported.
    Concentration(s) 2 mg per 1 mL

emSop, LLC